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The human gut microbiome contributes to human health and disease in a significant way. 
Moreover, its role in transformation and metabolism of xenobiotics has been well recognized. 
Dietary modulation of the gut microbiome received considerable attention due to the advantages 
of low toxicity profiles and high patient compliance. However, dietary recommendations to 
tackle gut microbiota-associated diseases such as intestinal inflammation are usually based on 
inconclusive or controversial evidence. A therapeutic approach to treat these diseases through gut 
microbiome modulation is highly desirable. Previous studies showed that arsenic exposure 
perturbed the gut microbiome and its metabolic functions, which may contribute to its toxicity. 
Modulation of the gut microbiome could potentially affect arsenic toxicity. The overall objective 
of this study was to develop and characterize a novel dietary approach based on black raspberries 
(BRB) for effective modulation of the gut microbiome that pushes the gut microbiome toward a 
desired state, resulting in protective effects for intestinal inflammation and arsenic toxicity. To 
accomplish the overall goal of this project, the following specific objectives were pursued: (i) to 
characterize the taxonomic and functional compositions of the BRB-modulated gut microbiome; 
(ii) to identify BRB-driven microbiome-derived metabolites that contribute to beneficial health 
effects; (iii) to determine the functional roles of BRB in mediating intestinal inflammation and 
arsenic biotransformation/toxicity through gut microbiome modulation. 
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Using a standardized BRB diet and mouse models, we characterized the functional 
alterations in addition to compositional changes in the gut microbiome upon modulation via 
dietary administration of BRB. Remarkable changes in the gut microbiome were revealed at both 
compositional and functional levels with an expected increase of Akkermansia muciniphila in 
concert with profound impacts on gut microbiome-related functions. Significantly-increased 
levels of beneficial metabolites and aryl hydrocarbon receptor (AHR) ligands were observed in 
the BRB-modulated gut microbiome, likely resulting from a combination of microbiome 
functional changes and unique precursors in BRB. Moreover, application of this modulation 
approach ameliorated intestinal inflammation in an AHR-dependent manner; and alleviated 
arsenic toxicity via alterations in related metabolic enzymes and cofactors. These findings 
provide insights regarding gut microbiome modulation as an attractive therapeutic approach for 
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CHAPTER 1 – GUT MICROBIOME TOXICITY AND GUT MICROBIOME 
MODULATION 
1.1 Introduction 
The human gut microbiome, including the microorganisms, their genomes, and the 
surrounding environment in the gut, has received unprecedented attention over the past decade 
(Marchesi & Ravel, 2015). Mounting evidence suggested that the metabolic activities in the gut 
microbiome are profoundly intertwined with human health and disease (Nicholson et al., 2012). 
A number of important functions performed by the gut microbiome are well recognized, 
including digestion of polysaccharides, biosynthesis of vitamins and nutrients, colonization 
resistance, and immune system modulation (Buffie et al., 2015; Koh, De Vadder, Kovatcheva-
Datchary, & Bäckhed, 2016; Sharon et al., 2014). Moreover, the effects of the gut microbiome on 
host metabolism and physiology extended beyond the gut to distant organs such as liver, muscle, 
and brain (Nicholson et al., 2012; Schroeder & Bäckhed, 2016). Owing to its crucial role in 
human fitness, the gut microbiome is now considered as a new organ in the human body 
(Baquero & Nombela, 2012; O'Hara & Shanahan, 2006). It is unequivocal that the gut 
microbiome functions properly on the premise that a normal gut microbial homeostasis is 
maintained (Nicholson et al., 2012). However, the constitution and functionality of the gut 
microbiome can be readily influenced by diverse intrinsic and extrinsic factors (Schmidt, Raes, 
& Bork, 2018). More importantly, exposure to various environmental chemicals leads to 
functional perturbation in the gut microbiome (Bian, Tu, et al., 2017; Claus, Guillou, & Ellero-
Simatos, 2016; Gao, Bian, Mahbub, & Lu, 2017; Gao, Tu, et al., 2017; Lu, Abo, et al., 2014). 
These environmental chemical-induced perturbations are potentially linked to elevated disease 
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risks (Cho & Blaser, 2012; Nicholson et al., 2012). Adverse health outcomes, including 
inflammatory bowel disease (IBD), obesity, diabetes, cardiovascular disease (CVD), liver 
disease, colorectal cancer, and neurological disorders, can be at least in part attributed to 
undesirable functional alterations in the gut microbiome (Collins, Surette, & Bercik, 2012; 
Hartstra, Bouter, Bäckhed, & Nieuwdorp, 2015; Louis, Hold, & Flint, 2014; Manichanh, Borruel, 
Casellas, & Guarner, 2012; Schnabl & Brenner, 2014; Tremlett, Bauer, Appel‐Cresswell, Finlay, 
& Waubant, 2017; Wang et al., 2011). 
Certain environmental toxins can induce damage and dysfunction in the liver, which is 
termed as liver toxicity. Exposure to these toxins changes the morphology and functionality of 
the liver hence leading to liver diseases. In comparison to liver, exposure to certain 
environmental chemicals causes structural differences and functional alterations in the gut 
microbiome, which probably results in a series of adverse health outcomes. As the gut 
microbiome is viewed as a new human organ by its importance, we accordingly define the 
environmental chemical-driven functional damage in the gut microbiome as gut microbiome 
toxicity. The development of gut microbiota-related diseases can be generalized as that 
environmental factors lead to deleterious alterations in the gut microbiome, which adversely 
affect human health via host-gut microbiota interactions. In other words, gut microbiome toxicity 
triggered by environmental exposures contributes to gut microbiota-related adverse outcomes. 
By including the gut microbiome toxicity into the organ toxicity family, we now can discuss the 
relationship between the environment and gut microbiota-related diseases in the context of 
toxicology (Figure 1.1). 
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Figure 1.1 A new member of the organ toxicity family: gut microbiome toxicity. Similarly, the 
discussion of gut microbiome toxicity encompasses environmental exposures, metabolic 
interactions in human diseases, assessment and modulation. 
Given the increasingly recognized role of the gut microbiome in human health coupled 
with its susceptibility to environmental insults, it is of significance to define gut microbiome 
toxicity. Environmental exposure is a significant risk factor for a series of human diseases, 
overlapping those diseases that are associated with the gut microbiome (Alavanja, Hoppin, & 
Kamel, 2004; Ananthakrishnan, 2015; Thayer, Heindel, Bucher, & Gallo, 2012). Thus, gut 
microbiome toxicity may be the missing link between the environmental exposure and 
microbiome-related human diseases. In addition, the current toxicity testing system does not 
include toxic endpoints regarding the effects of environmental chemicals on the gut microbiome. 
Considering the involvement of the gut microbiome in human disease, it is imperative to 
integrate the gut microbiome toxicity into the toxicity assessment of environmental exposure. 
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Thus, the establishment of gut microbiome toxicity may offer insights regarding the mechanistic 
basis underlying the toxicity of environmental chemicals, calling for more comprehensive risk 
assessment with integration of the gut microbiome toxicity. 
Here, we carefully define the gut microbiome toxicity as environmental chemical-driven 
functional damage in the gut microbiome. We focus on recent studies in support of the 
establishment of the gut microbiome toxicity, and we accordingly discuss the environmental 
exposures, metabolic interactions in human disease, assessment and modulation (Figure 1.1). 
Specifically, we review recent studies demonstrating the functional perturbation in the gut 
microbiome driven by various environmental chemicals. These functional changes include but 
not limit to alterations in bacterial production of metabolites, diversity loss and interference in 
energy metabolism, which are further linked to the development of gut microbiota-related 
diseases. Additionally, we briefly summarize current approaches for the assessment of gut 
microbiome toxicity as well as effective gut microbiome modulation. 
1.2 Environmental exposures 
The fact that a number of environmental chemicals can trigger gut microbiome toxicity 
suggests the underestimation of toxic effects from various environmental exposures. On one 
hand, to induce gut microbiome toxicity may be a potential new mechanism by which known 
toxic chemicals (e.g. heavy metals, pesticides) lead to or exacerbate human diseases. On the 
other hand, it is of necessity to reconsider the health effects and acceptable daily intake (ADI) of 
wildly used chemicals such as food additives. The impact of environmental chemicals on the 
human gut microbiome can be direct or indirect. The human gut microbiome encodes more 
diverse metabolic enzymes which greatly expands the repertoire of biochemical reactions within 
the human body (Koppel, Rekdal, & Balskus, 2017). The environmental chemicals can directly 
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affect the gut bacteria by interrupting specific metabolic pathway or gene expression, leading to 
distinct selective pressures hence shaping the gut microbial community due to the uniqueness of 
the set of metabolic pathways and genome possessed by different bacterial species (Koppel et al., 
2017). Also, environmental chemicals can indirectly impact the gut microbiome through the 
influence on host physiology (e.g. gut mucosa (Zhang et al., 2015)) and cell-to-cell 
communications of bacteria (e.g. quorum sensing (Thompson, Oliveira, Djukovic, Ubeda, & 
Xavier, 2015)). That being said, the mechanistic basis underlying the microbial perturbation 
induced by specific chemical exposure remains elusive. Here, we highlight representative 
environmental chemicals that cause gut microbiome toxicity with significant functional 
alterations. 
1.2.1 Antibiotics/Drugs 
It is commonly accepted that antibiotic administration, especially broad-spectrum 
antibiotics, severely impacts commensal bacteria. Both short-term and long-term antibiotic 
treatments lead to gut microbiome toxicity, although partial recovery may occur (Becattini, Taur, 
& Pamer, 2016; Langdon, Crook, & Dantas, 2016). In many cases, effects of antibiotics on 
bacterial communities result in diversity loss and compositional imbalance (Lozupone, 
Stombaugh, Gordon, Jansson, & Knight, 2012). Moreover, antibiotics not only disturbs the gut 
microbiome at the compositional level but also substantially changes its functional profiles. For 
example, a recent study used a multi-omics approach to resolve the changes induced by beta-
lactam in human gut microbiome (Pérez-Cobas et al., 2012). The results showed that beta-lactam 
treatment caused both taxonomic and functional alterations in gut microbiome supported by 
alterations at metagenomic, metatranscriptomic, metametabolomic and metaproteomic levels. 
Antibiotics-induced gut microbiome toxicity has been linked to human diseases such as obesity 
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and diabetes (Cho et al., 2012; Livanos et al., 2016). Besides antibiotics, non-antibiotic drugs 
also affect the gut microbiome (Le Bastard et al., 2018). For instance, metformin (Forslund et al., 
2015), non-steroidal anti-inflammatory drugs (Rogers & Aronoff, 2016), proton pump inhibitors 
(Imhann et al., 2015) and atypical antipsychotics (Flowers, Evans, Ward, McInnis, & Ellingrod, 
2017) are reported to have effects on the gut microbiome although the health consequences 
remain underexplored. A most recent study tested 1,200 marketed drugs by in vitro screening to 
investigate their effects on the gut microbiome. A quarter of human-targeted drugs were 
discovered to have effects on the gut bacteria to some degree, indicating the potential of 
medication to induce gut microbiome toxicity. 
1.2.2 Heavy metals 
Heavy metals continue to be a class of intensely-studied environmental contaminants. 
However, the role of heavy metals in the gut microbiome toxicity still remains underappreciated. 
In fact, the gut bacteria play an important role in the biotransformation of heavy metals which 
may promote or attenuate their toxicity. For example, human gut bacteria are able to transform 
inorganic arsenic into less toxic organic arsenic species (Van de Wiele et al., 2010); 
Demethylation of methyl-mercury by gut bacteria can generate more toxic inorganic mercury 
(Liebert, Wireman, Smith, & Summers, 1997). Rats exposed to heavy metals including arsenic, 
cadmium, cobalt, chromium and nickel exhibited significant changes in their gut microbial 
compositions (Richardson et al., 2018). Moreover, the functional profiles in the gut microbiome 
can be perturbed by heavy metals. 4 weeks arsenic exposure (10 ppm) caused significantly 
different metabolite profiles in the mouse gut microbiome (Lu, Abo, et al., 2014). Likewise, 13 
weeks arsenic exposure with an environment-relevant dose (100ppb) also perturbed diverse 
bacterial metabolic pathways (Chi, Bian, et al., 2017). Arsenic-induced gut microbiome toxicity 
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provided a new angle regarding the mechanism of arsenic toxicity. Follow-up studies further 
demonstrated that arsenic-induced gut microbiome toxicity can be affected by factors including 
host genetics (Lu, Mahbub, et al., 2014), gender (Chi et al., 2016) and bacterial infection (Lu et 
al., 2013). In addition, exposure to manganese and lead disturbs the gut microbial functions of 
mice with perturbed pathways and metabolites (Chi, Gao, et al., 2017; Gao, Chi, et al., 2017). 
1.2.3 Pesticides 
Excessive use of pesticides in agriculture has raised concern about their health effects. 
The argument that certain pesticides are safe to human because their targeted pathways do not 
even exist in human body fails to consider the microbes in the gut (Samsel & Seneff, 2013). For 
example, herbicides that impact plant hormones (2,4-D) may affect gut bacteria because not only 
plant but also bacteria can synthesize plant hormones (Costacurta & Vanderleyden, 1995). 
Likewise, shikimate pathway, the target of herbicide glyphosate, is commonly present in human 
gut bacteria (Amrhein, Deus, Gehrke, & Steinrücken, 1980; Hashimoto et al., 2012). Several 
studies have demonstrated the association between gut microbiome toxicity and pesticide 
exposure. For example, the fungicide imazalil changed the composition of gut microbiome in 
zebrafish and mice (Jin, Luo, et al., 2017; Jin, Xia, et al., 2017). Of interest, a recent study 
showed that the mouse gut microbiome was perturbed by 13 weeks diazinon exposure (4 ppm) 
(Gao, Bian, Mahbub, et al., 2017). Bacterial genes and metabolites involved in neurotransmitter 
synthesis were significantly perturbed, suggesting that diazinon-induced gut microbiome toxicity 
with altered bacterial biosynthesis of neurotransmitter may be partially responsible for the 
neurotoxicity of diazinon (Slotkin, Ryde, Levin, & Seidler, 2008; Timofeeva, Roegge, Seidler, 
Slotkin, & Levin, 2008). In addition, exposure to diazinon and malathion impacts the quorum 
sensing of gut bacteria, providing evidence that affecting bacterial communications may be one 
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of the underlying mechanisms of gut microbial perturbations (Gao, Bian, Chi, et al., 2017; Gao et 
al., 2018). 
1.2.4 Artificial sweeteners 
Food additives have facilitated the development of modern food industry. Normally food 
additives (e.g. artificial sweeteners, emulsifiers, preservatives) are added in food products with 
approved safe amount. Nevertheless, the gut microbiome toxicity was not being taken into 
consideration when related standards were determined. Many artificial sweeteners are considered 
safe because they are poorly metabolized by human body (Koppel et al., 2017). However, the gut 
bacteria are actively involved in the biotransformation. For example, cyclamate, which is 
currently banned in the U.S., can be metabolized by gut bacteria into cyclohexylamine that is 
carcinogenic (Drasar, Renwick, & Williams, 1972). Artificial sweeteners stevioside and xylitol 
can also be metabolized by the gut bacteria (Krishnan et al., 1980; Renwick & Tarka, 2008). 
Several studies have demonstrated that some artificial sweeteners and emulsifiers were able to 
induce gut microbiome toxicity with potential gut microbiota-related health consequences. For 
instance, in an elegantly conducted study by Suez and colleagues, consumption of saccharin 
induced both compositional and functional changes in mouse gut microbiome that might be 
involved in the development of glucose intolerance (Suez et al., 2014). Another study reported 
similar results with increased inflammatory levels in addition to gut microbial perturbation 
induced by saccharin in mice (Bian, Tu, et al., 2017). Additionally, artificial sweeteners 
acesulfame potassium (Bian, Chi, et al., 2017a), sucralose (Bian, Chi, et al., 2017b) and neotame 
(Chi et al., 2018) can also induce gut microbiome toxicity with perturbed bacterial metabolites in 
concert with health implications including obesity and inflammation. Moreover, another study 
found that two commonly used emulsifiers altered mouse gut microbial composition together 
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with elevated inflammatory levels (Chassaing et al., 2015). 
1.2.5 Others 
The above discussion is not intended to be exhaustive. A rapidly-increasing list of 
environmental chemicals is linked to the gut microbiome toxicity. Some are commonly present in 
our daily life; a typical example is the antibacterial and antifungal agent triclosan. It was 
repeatedly reported that triclosan induced changes in the gut microbiome using multiple animal 
models (Gao, Tu, et al., 2017; Gaulke, Barton, Proffitt, Tanguay, & Sharpton, 2016; Hu et al., 
2016; Narrowe et al., 2015).However, the effects of triclosan on human gut microbiome remain 
controversial (Poole et al., 2016). Furthermore, exposure to nicotine from smoking also 
perturbed the gut microbiome affecting bacterial production of neurotransmitters (Chi, Mahbub, 
et al., 2017). Such a large range of chemicals that may induce gut microbiome toxicity supports 
the necessity of considering gut microbiome toxicity regarding the toxicity evaluation of 
environmental chemicals. 
1.3 Interactions between the gut microbiome toxicity and human diseases 
The mutually beneficial relationship between the gut microbiome and the host is built on 
the premise that a well-balanced gut microbiota is maintained (Nicholson et al., 2012). However, 
when afflicted with the gut microbiome toxicity, functional alterations occur in the gut 
microbiome. Although it is difficult to disentangle those alterations, changes in microbial 
metabolites, diversity loss and interference in energy metabolism are three major type of 
microbial disturbances that may adversely impact the host health via multiple host-microbiota 
axes, potentially leading to increased diseases risks. Therefore, gut microbiome toxicity is a new 
link between the environment and human diseases. In this part, we discuss the connection 
between the gut microbiome toxicity and human diseases, providing some mechanistic insights 
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regarding gut microbiome-associated diseases. 
1.3.1 Changes in microbial metabolites 
Production of functional metabolites by bacteria plays a key role in human health and 
disease (Sharon et al., 2014). Gut microbiome toxicity comes with a differentiated bacterial 
metabolite profile, which influences host metabolism and physiology in a significant way. First, 
numerous bacterial metabolites act as signaling molecules through binding to receptors and 
activating diverse signaling cascades. Pathogen-associated molecular patterns, 
lipopolysaccharide and peptidoglycan can bind to Toll-like receptor 4 (TLR4) and nucleotide-
binding oligomerization domain (NOD), respectively; both of which lead to pro-inflammatory 
effects (Amar et al., 2011; Cani et al., 2007; Schertzer et al., 2011). Classic metabolites of gut 
bacteria, short-chain fatty acids (SCFAs) and bile acids, can also function as signaling molecules 
and bind to cellular receptors. Specifically, SCFAs can bind to G-protein-coupled receptors 
(GPCRs), and bile acids can bind to GPCR TGR5 and nuclear receptor farnesoid X receptor 
(FXR) (Tremaroli & Bäckhed, 2012). Activation of signaling pathways is implicated in 
important biological functions, the gut microbiome may therefore contribute to human health and 
disease by regulating metabolic activities involved in SCFAs and bile acids. For instance, SCFAs 
and bile acids can modulate the secretion of glucagon-like peptide-1 (GLP-1) by binding to 
GPR43 (Tolhurst et al., 2011) and TGR5 (Thomas et al., 2009) respectively, which affects insulin 
secretion and glucose homeostasis. Perturbation in those bacterial activities may lead to an 
increased risk of diabetes. In addition, tryptophan metabolites by bacteria such as indole 3-
propionic acid and indole-3-acetic acid regulate intestinal immune cells and barrier functions 
through the activation of aryl hydrocarbon receptor (AHR) and the pregnane X receptor (PXR) 
(Lamas et al., 2016; Venkatesh et al., 2014; Zelante et al., 2013). AHR activation is involved in 
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IBD, and it is suggested that reduction in bacterial tryptophan metabolism may contribute to IBD 
(Lamas et al., 2016). Second, some bacterial metabolites are strongly associated with specific 
diseases and phenotypes. A compelling example is the association of trimethylamine N-oxide 
(TMAO) and cardiovascular disease (Wang et al., 2011). The gut bacteria can convert dietary 
components choline and L-carnitine to trimethylamine (TMA), which is further metabolized into 
TMAO in liver. Gut microbiome-derived TMAO is highly correlated with cardiovascular disease 
risks. Likewise, products of protein fermentation (e.g. N-nitroso compounds, polyamines) 
derived by gut bacteria exert carcinogenetic effects and promote colorectal cancer (Louis et al., 
2014). Third, the gut-brain axis is increasingly recognized. Mounting evidence suggests that 
brain function and behavior can be affected by gut bacterial metabolites, many of which are 
neurotransmitters or their precursors (e.g. serotonin, gamma-aminobutyric acid) (Sharon et al., 
2014). As mentioned in the exposure part, bacterial metabolites that are neurotransmitters were 
perturbed by environmental chemicals such as organophosphate diazinon and nicotine, which 
may partially explain their neurotoxicity. Additionally, gut microbiome is an important source of 
beneficial vitamins and nutrients, reduction in bacterial production of those beneficial 
metabolites is detrimental to human health. Taken together, the gut microbiome toxicity can lead 
to diseases via differentiated metabolite profiles. 
1.3.2 Diversity loss 
Diversity loss has been associated with many microbiota-related diseases such as IBD 
(Dicksved et al., 2008; Frank et al., 2007), irritable bowel syndrome (IBS) (Carroll et al., 2011), 
acute diarrhea (Young & Schmidt, 2004) and Clostridium difficile-associated disease (CDAD) 
(Chang et al., 2008). Trillions of microorganisms residing in the human gut form a complex 
microbial ecosystem, which is deeply intertwined with human biology (Lozupone et al., 2012). 
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Therefore, it is important to view the gut microbiome from an ecological perspective although it 
is formidable due to fluctuations over time and variations between individuals (Lozupone et al., 
2012). Resilience is the extent of perturbation that an ecosystem can tolerate before it 
equilibrates towards a different state (Folke et al., 2004). Resilience of the gut microbiome is 
crucial to colonization resistance to pathogens (Lozupone et al., 2012; van der Waaij, Berghuis, 
& Lekkerkerk, 1972). The diversity including species richness and evenness of the gut microbial 
community confers to its resilience. Gut microbiome with species-rich communities is less 
susceptible to perturbation and stress because different species are specialized to each 
potentially-limiting resources (Levine & D'antonio, 1999). Moreover, high species richness 
enables alternative species with similar functions to fill a niche and maintain the diversity when 
the original species is compromised (Elmqvist et al., 2003). The diversity of the gut microbial 
ecosystem can be compromised by environmental factors (e.g. antibiotics), which makes it less 
resilient and more susceptible to pathogen invasion. For instance, antibiotics can induce changes 
in the gut microbiome and metabolic features that increased its susceptibility to Clostridium 
difficile infection (Theriot et al., 2014). In addition, a core set of gut microbial species does not 
exist because of marked differences in present species and their relative abundances across 
individuals. However, a functional core microbiome is shared with similar functional gene 
profiles (Turnbaugh et al., 2009). To maintain the functional core microbiome is indispensable. 
Normal functioning of the human biology partially relies on the essential functions performed by 
the gut microbiome. However, exposure to environmental chemicals shatters the integrity of the 
gut microbial ecosystem, leading to loss of functions in the gut microbiome hence compromising 
host health. 
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1.3.3 Interference in energy metabolism 
Accumulating evidence suggested that the gut microbiome plays a crucial role in energy 
metabolism. Human cannot degrade most plant polysaccharides, which instead, can be utilized 
by the gut bacteria producing SCFAs that are important energy substrates (Tremaroli & Bäckhed, 
2012). Direct evidence supporting the role of the gut microbiome in energy balance is that germ-
free rats have reduced intestinal levels of SFCAs and doubled excretion of calories through urine 
and feces (Høverstad & Midtvedt, 1986; Wostmann, Larkin, Moriarty, & Bruckner-Kardoss, 
1983). It is suggested that the capacity for energy harvest of the gut microbiome is correlated 
with its microbial composition (Turnbaugh et al., 2006), in specific, the ratio of two major phyla 
Firmicutes and Bacteroidetes. Moreover, enriched genes encoding enzymes that are important 
for the initial steps of complex carbohydrate metabolism were found in the gut microbiome of 
obese mice (Turnbaugh et al., 2007). Studies showed that the energy balance and body weight of 
the host is associated with the gut microbiome types. For instance, germ-free mice with fecal 
microbiota transplantation from obese mice gained more weight than that from lean mice 
(Turnbaugh et al., 2006). Likewise, mice with the microbiota from people afflicted with 
Kwashiorkor, a form of malnutrition, suffered severe weight loss (Smith et al., 2013). Thus, it is 
possible that gut microbiome toxicity interferes with the energy extraction and harvest, leading to 
diseases such as obesity or malnutrition. 
To summarize, exposure to environmental chemicals such as heavy metals and artificial 
sweeteners induces gut microbiome toxicity. Compositional alterations and functional changes 
occur along with this progress in the gut microbiome. These chemical-induced perturbations lead 
to human diseases via several mechanisms including changes in the metabolite profiles, diversity 
loss and altered energy metabolism (Figure 1.2). 
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Figure 1.2 Schematic representation of how gut microbiome toxicity connects environment and 
microbiota-associated diseases. 
1.4 Assessment of gut microbiome toxicity 
The gut microbiome toxicity fails to be taken into consideration regarding the toxicity 
testing and evaluation of environmental toxic chemicals. There is no toxic endpoint currently 
established to report the relative toxic effects of certain chemical on the gut microbiome. Thus, it 
is imperative to assess the functional alterations induced by various environmental chemicals, or 
at least the chemicals of frequent and long-term exposure (e.g. artificial sweeteners). Current 
approaches for the assessment of gut microbiome toxicity mainly comprise an integration of 
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animal models (e.g. mouse, rat) and the meta-omics toolkit (Schmidt et al., 2018). The use of 
animal models enables us to mimic the progress of gut microbiome toxicity under environmental 
exposures; the meta-omics toolkit comprises sequencing-based gene profiling and mass 
spectrometry-based metabolite profiling. In terms of assessment levels, meta-omics comprise 
approaches of compositional levels and functional levels. Compositional profiling, that is, 
taxonomic profiling provides details of the microbial constitution, diversity and structure. 
However, knowing the taxonomic information alone does not necessarily lead to an accurate 
understanding of its functions due to the existence of functional redundancy in the microbiome 
(Lozupone et al., 2012). In the context of gut microbiome toxicity, the functional changes 
including the genes, mRNAs, proteins and metabolites are what we should emphasize. 
Furthermore, humanized gnotobiotic mice with gut microbiota more similar to human allow 
better elucidation of the interactions between human gut microbiome and environment (Nguyen, 
Vieira-Silva, Liston, & Raes, 2015). The use of germ-free mice and in vitro techniques extends 
the observational studies to causality (Schmidt et al., 2018). The accurate assessment of gut 
microbiome toxicity provides knowledge of how gut microbes react to environmental exposures, 
offering insights on mechanistic basis of chemical-induced microbial perturbations and 
diagnostic makers for microbiota-associated diseases. 
1.5 Gut microbiome modulation 
The gut microbiome is becoming an attractive therapeutic target especially now with its 
role well recognized in human health and disease. Current approaches for gut microbiome 
modulation including fecal microbiota transplantation (FMT), probiotics, and prebiotics, are 
mainly untargeted without predictable outcomes (Schmidt et al., 2018). To move from untargeted 
toward targeted modulation, a healthy gut microbiome need to be defined. A consensus on the 
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healthy endpoints of gut microbiome modulation remains elusive, which is a major challenge 
(Lloyd-Price, Abu-Ali, & Huttenhower, 2016). Nevertheless, the potential of targeted, 
hypothesis-driven gut microbiome modulation has been demonstrated in some recent studies. 
Use of whole foods or food components as dietary intervention to modulate the gut microbiome 
has received increasing attention owing to their low toxicity profiles and high patient 
compliance. Here, we use Akkermansia muciniphila (A. muciniphila) as an example to review 
recent progress on attempts at targeted microbiome modulation. 
A. muciniphila, a mucin-degrading bacterium commonly present in human and mouse gut 
microbiome, has many probiotics functions in gut barrier function, glucose homeostasis and 
inflammation in human and diverse animal models (Derrien, Belzer, & de Vos, 2017; Everard et 
al., 2013; Greer et al., 2016; Li, Lin, Vanhoutte, Woo, & Xu, 2016; Schneeberger et al., 2015). 
Several studies reported targeted gut microbiome modulation with increased A. muciniphila 
population via consumption of whole foods or food components. For example, consumption of 
several berry fruits including cranberries and raspberries promoted A. muciniphila in the gut 
microbiome. Specifically, cranberry extract improved insulin sensitivity and reduced weight gain 
in concert with a significant increase of A. muciniphila in mice of diet-induced obesity (Anhê et 
al., 2014). Likewise, black raspberries boosted A. muciniphila population in the gut microbiome 
together with profound changes in microbial functions including vitamin biosynthesis, aromatic 
amino acid metabolism, carbohydrate metabolism, and oxidative stress (Tu et al., 2018). The 
polyphenols abundant in berry fruits could be a reason that A. muciniphila thrives. Feeding 
polyphenols from grapes to mice showed similar results with a drastic increase of A. muciniphila 
(Roopchand et al., 2015). The gut microbiome offers a link between polyphenols and their 
diverse beneficial effects because polyphenols are poorly absorbed and metabolized by the 
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human body (Roopchand et al., 2015). On the other hand, A. muciniphila uses mucin as carbon, 
nitrogen and energy sources (Derrien, Vaughan, Plugge, & de Vos, 2004). Goblet cells are the 
major producer of mucin in the intestinal epithelium (Linden, Sutton, Karlsson, Korolik, & 
McGuckin, 2008). It is reported that the number of goblet cells and the thickness of intestinal 
mucosa were increased in rats fed oligofructose (Kleessen, Hartmann, & Blaut, 2003). Therefore, 
oligofructose may be an alternative factor for the increase of A. muciniphila in mice fed berries, 
which is supported by the study that administration of oligofructose did increase the A. 
muciniphila population in the gut microbiome of mice (Everard et al., 2011). Of particular 
interest, metformin, medication to treat type 2 diabetes, also promotes A. muciniphila population 
in the gut microbiome, which is believed to contribute to its therapeutic effects (De La Cuesta-
Zuluaga et al., 2016; Wu et al., 2017). Perturbation by environmental toxic chemicals and 
modulation by dietary components regarding the gut microbiome are fundamentally similar 
except with different expected outcomes. Knowledge of how gut microbes react to 
environmental chemicals and dietary components will address gaps in our understanding of both 
perturbation and modulation of the gut microbiome. 
1.6 Objectives 
This study proposes a BRB-based approach for the gut microbiome modulation to cope 
with microbiome-associated adverse outcomes including gut microbiome toxicity. Our 
preliminary results showed that BRB consumption drastically increased A. muciniphila 
population in mouse gut microbiome, which is a mucin-degrading bacterium with probiotic 
functions. Shotgun metagenomic sequencing and metabolomic profiling were applied to further 
characterize the functional profile including metabolic pathways and metabolites in addition to 
compositional changes in the gut microbiome of mice with BRB consumption. In particular, 
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BRB-modulated gut microbiome content exhibited significantly higher aryl hydrocarbon 
receptor (AHR) activation. Given the essential role of AHR in inflammatory response and 
xenobiotic metabolism, we examined the effects of the gut microbiome modulation approach on 
intestinal inflammation and arsenic toxicity using animal models with treatment of dextran 
sulfate sodium (DSS) and arsenite. 
1.6.1 Overall research goal 
The overall objective of this study was to develop and characterize a novel dietary approach 
based on BRB for effective modulation of the gut microbiome that pushes the gut microbiome 
toward a desired state, resulting in protective effects for intestinal inflammation and arsenic 
toxicity (Figure 1.3). 
 
Figure 1.3 Schematic representation of specific objectives of this study. 
1.6.2 Specific objectives  
To achieve the overall research goal, the following specific objectives were pursued: 
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Objective 1. Characterize the taxonomic and functional compositions of the BRB-modulated gut 
microbiome.  
Objective 2. Identify BRB-driven microbiome-derived metabolites that contribute to beneficial 
health effects. 
Objective 3. Determine the functional roles of BRB in mediating intestinal inflammation and 
arsenic biotransformation/toxicity through gut microbiome modulation.  
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1.7 Dissertation organization 
This dissertation comprises six chapters. Chapter 1 introduces the concept of ‘gut 
microbiome toxicity’, and objectives of this research, setting the framework for following 
chapters. Chapters 2-5 offers detailed research descriptions to address the overall and specific 
goals of the dissertation and each chapter is independently comprehensive with introduction, 
materials and methods, results and discussion, acknowledgements, and reference sections. 
Chapter 6 summarizes the results from Chapters 2-5, proposes potential mechanisms and 
suggests future avenues of research to extend this work. The appendices following Chapter 6 
include supporting information referenced in Chapters 2-5. Chapters 2-5 are briefly described 
below: 
Chapter 2: This chapter addresses specific objective 1. In this chapter, taxonomic and 
functional characterization of the gut microbiome of mice with the treatment of the BRB diet 
was conducted. We examined the effects of the BRB diet as a novel approach to reshape the gut 
microbiome by selectively boosting A. muciniphila population. Remarkable changes of the 
mouse gut microbiome were revealed at both compositional and functional levels with an 
expected increase of Akkermansia muciniphila in concert with a profound impact on multiple gut 
microbiome-related functions, including vitamin biosynthesis, aromatic amino acid metabolism, 
carbohydrate metabolism and oxidative stress. We proposed a readily-translatable approach using 
an easily-accessed freeze-dried BRB-supplemented diet for effective modulation of mouse gut 
microbiome by targeting A. muciniphila, offering a new strategy to improve human health by gut 
microbiome modulation via BRB-rich diets.  
Chapter 3: This chapter addresses specific objective 2. In this chapter, we examined the 
metabolome differences in the gut microbiome driven by BRB consumption via targeted and 
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untargeted metabolomic approaches. A distinct metabolite profile was observed in the gut 
microbiome of mice with BRB consumption, likely resulting from a combination of microbiome 
functional changes and unique precursors in BRB. A number of functional metabolites, such as 
tetrahydrobiopterin and butyrate that were significantly increased in the gut microbiome may be 
linked to the beneficial health effects from BRB consumption.  
Chapter 4: This chapter addresses specific objective 3 emphasizing intestinal 
inflammation. In this chapter, we investigated the role of microbiome-derived AHR ligands in 
intestinal inflammation via an integration of a mouse model of experimental colitis and a 
standardized BRB-based dietary intervention. The results show that the BRB dietary intervention 
ameliorated the intestinal inflammation in mice in an AHR-dependent manner. With the BRB 
dietary intervention, perturbations in the gut microbiota associated with colitis were partially 
restored. Furthermore, increased levels of AHR ligands in the diet-modulated gut microbiome 
resulted in elevated AHR activation, which may contribute to the ameliorating effect on intestinal 
inflammatory status. Enriched bacterial genes and pathways in the biosynthesis of AHR ligands, 
such as heme-related compounds, in concert with strong correlations between specific bacterial 
species and these compounds, suggested the involvement of gut bacterial activities in producing 
AHR ligands. Host metabolic profiling revealed restored metabolites that are relevant to 
inflammation and the gut microbiota. These findings provide insights regarding microbiome 
production of AHR ligands as an attractive therapeutic target of intestinal inflammation via gut 
microbiome modulation. 
Chapter 5: This chapter addresses specific objective 3 emphasizing arsenic toxicity. In 
this chapter, we used a mouse model combined with a standardized BRB-rich diet to investigate 
the impact of BRB consumption on arsenic biotransformation. We observed a significant 
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reduction of urinary 8-oxo-2′-deoxyguanosine (8-oxodG) together with elevated levels of 
methylation and urinary excretion of arsenic in mice concurrently fed BRB upon arsenic 
exposure. Moreover, enzyme expression and liver metabolites involved in arsenic metabolism 
were found to be different between mice on BRB and control diets with arsenic exposure. These 
data indicate that BRB consumption affected arsenic biotransformation in vivo likely via 
alterations in related metabolic enzymes and cofactors, providing evidence on reduction of 
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CHAPTER 2 – CHARACTERIZATION OF THE FUNCTIONAL CHANGES IN MOUSE 
GUT MICROBIOME ASSOCIATED WITH INCREASED AKKERMANSIA 
MUCINIPHILA POPULATION MODULATED BY DIETARY BLACK RASPBERRIES * 
2.1 Introduction 
Our gut microbiota, which consists of up to 100 trillion microorganisms, encodes 100 
times more genes than our own genome (Bäckhed, Ley, Sonnenburg, Peterson, & Gordon, 2005). 
The human body interacts with the gut bacteria in numerous ways. For instance, microbial 
fermentation of dietary fiber produces short-chain fatty acids (SCFAs), such as butyrate, acetate 
and propionate, which are not only energy substrates but also involved in diverse signaling 
pathways (Tremaroli & Bäckhed, 2012). However, growing evidence shows that the gut 
microbiome and its metabolic functions can be readily perturbed by exposure to environmental 
toxic agents such as heavy metals or pesticides (Gao, Bian, Chi, et al., 2017; Gao, Bian, Mahbub, 
& Lu, 2017; Lu et al., 2014). Disrupted gut microbiome (dysbiosis) is frequently associated with 
adverse health outcomes such as obesity or a compromised immune system (Kau, Ahern, Griffin, 
Goodman, & Gordon, 2011; Tilg & Kaser, 2011), and we define such perturbed gut microbiome 
as an unhealthy one. An unhealthy gut microbiome caused by environmental insults would lead 
to numerous adverse health effects and its compositional and functional characteristics can be 
partially responsible. For example, the high Firmicutes/Bacteroidetes ratio in gut microbial 
                                                             
* This chapter previously appeared as an article in ACS omega. The original citation is as follows: Tu, P., 
Bian, X., Chi, L., Gao, B., Ru, H., Knobloch, T. J., ... & Lu, K. (2018). Characterization of the Functional 
Changes in Mouse Gut Microbiome Associated with Increased Akkermansia muciniphila Population 
Modulated by Dietary Black Raspberries. ACS omega, 3(9), 10927-10937. 
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composition is associated with obesity, and the gut microbiome in obese individuals has 
enhanced microbial functions for energy extraction than that present in lean individuals 
(Turnbaugh, Bäckhed, Fulton, & Gordon, 2008). Bäckhed, et al. described the healthy 
microbiome as a microbial community with structure and function that presumably confer health 
benefits for the host (Bäckhed et al., 2012). Therefore, it is of significance to be able to modulate 
the gut microbiome towards a bacterial community profile that promotes “healthy” outcomes. 
Currently, a simple, effective and selective approach with the potential for broad applicability has 
not been adequately explored yet. In recent years, a series of patterns for gut microbiome 
alterations associated with various diseases have been documented, but the functional impact of 
those changes still remains elusive (Bäckhed et al., 2012). A number of gut bacteria have proven 
health-associated functions and clinical efficacy. For instance, probiotics strains present in 
Lactobacillus and Bifidobacterium genera are able to confer a health benefit in human when 
treating gastrointestinal disorders (Bäckhed et al., 2012). Thus, encouraging beneficial and 
inhibiting detrimental bacteria would be a reasonable approach to transform the gut microbiome 
into one that confers health benefits, and the investigation on the consequent functional changes 
resulting from compositional alterations is also warranted. 
A number of recent studies have demonstrated that Akkermansia muciniphila (A. 
muciniphila), commonly found in human and mouse gut microbiome, plays a key role in 
regulating glucose homeostasis, inflammation, gut barrier function, adipose tissue metabolism, 
fat mass storage and host metabolic functions in diverse animal models and human (Dao et al., 
2016; Derrien, Belzer, & de Vos, 2017; A. Everard et al., 2013; Amandine Everard & Cani, 2013; 
Gomez-Gallego, Pohl, Salminen, De Vos, & Kneifel, 2016; Greer et al., 2016; Li, Lin, Vanhoutte, 
Woo, & Xu, 2016; Schneeberger et al., 2015; Shen et al., 2017; Wang et al., 2011; Zhao et al., 
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2017). It has been shown that the development of obesity and associated metabolic disorders 
could be attenuated by A. muciniphila treatment (A. Everard et al., 2013). In this context, 
methods to selectively increase A. muciniphila are highly desired. We propose a simple approach 
for the modulation of the gut microbiome by boosting A. muciniphila with a black raspberry 
(Rubus occidentalis, BRB)-rich diet. We hypothesize that BRB could lead to a notable increase 
of A. muciniphila, thus modulating the gut microbiome and its metabolic functions to provide 
health benefits to the host. We used whole, ripe, freeze-dried BRB in this study with the intent to 
increase A. muciniphila, hence reshaping the mouse gut microbiome. The rationale for this 
choice is that it has been reported that the gut microbiota was shifted in rats fed with a diet 
supplemented with freeze-dried berries (Jakobsdottir et al., 2013; Pan et al., 2017). In particular, 
oligofructose and polyphenols are both abundant in berry fruits and administration of 
oligofructose and dietary polyphenols can increase the A. muciniphila population in mice 
(Amandine Everard et al., 2011; Roopchand et al., 2015). Given the pivotal role played by the 
gut microbiome in human health as well as the ability of BRB to modify the gut microbiota, the 
BRB have the potential to modulate mouse gut microbiome by increasing the beneficial gut 
bacteria, such as A. muciniphila, hence promoting host health and decreasing disease risk. 
Furthermore, it is also relevant and applicable to elucidate metabolic function changes associated 
with the gut microbiome modulation by BRB. 
A BRB-rich diet was employed to directionally modulate the mouse gut microbiome. We 
combined 16S rRNA gene sequencing and shotgun metagenomics sequencing to investigate the 
interplay between the gut microbiome and the BRB-supplemented diet. The gut microbial 
profiles after 7-week BRB diet examined by 16S rRNA sequencing and metagenomics 
sequencing showed a significantly-altered the gut microbial composition in C57BL/6 mice with a 
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157-fold A. muciniphila in concert with a remarkable impact on the microbiome-related 
functions including vitamin biosynthesis, aromatic amino acid metabolism, carbohydrate 
metabolism and oxidative stress that can potentially influence host health. 
2.2 Materials and methods 
2.2.1 Animals and BRB diet preparation 
A total of 20 specific-pathogen free C57BL/6 mice (~8-week old), purchased from 
Jackson Laboratories, were housed in the animal facility of the University of Georgia for one 
week to acclimate with standard pelleted rodent diet and tap water ad libitum provided (protocol 
number: A2013 06-033-Y3-A3). The BRB diet was prepared essentially as previously described 
(Oghumu et al., 2017). Briefly, whole ripe BRB of the Jewel variety were freeze-dried and 
ground into powder. BRB powder was stored at −20°C until being incorporated into custom 
purified American Institute of Nutrition (AIN)-76A animal diet pellets (Protein 20.8kcal%; 
Carbohydrate 67.7kcal%; Fat 11.5kcal%) (Bieri, 1980) by 10% w/w concentration at the expense 
of cornstarch. The diets were stored at 4°C until being fed to animals. Mice of control diet 
groups were fed AIN-76A diet, mice of dietary intervention groups were fed BRB diet. The BRB 
diet used in the present study was previously used in a large number of studies for 
chemopreventive effects as well as microbiome modulation (Aiyer, Srinivasan, Gupta, & cancer, 
2008; Casto et al., 2002; Harris et al., 2001; Kresty et al., 2001; G. D. Stoner et al., 2007; Tu et 
al., 2018). Its preparation was standardized to ensure consistency and reproducible results. All 
berries of a single variety were harvested from a single farm in Southern Ohio. Chemical 
characterization of 26 randomly-selected functional components including simple phenols and 
athocyanins has been conducted for standardization purposes, which together with further details 
regarding the BRB diet was previously discussed and reviewed (Stoner, 2009). 
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In the beginning of the diet treatment, mice were randomly assigned to either control 
(AIN-76A diet) or treatment group (BRB diet). They were housed under the environmental 
conditions of 22°C, 40–70% humidity, and a 12:12 hr light:dark cycle and were provided water 
ad libitum throughout the experiment period. Regular monitoring for health conditions was twice 
a week. After 7 weeks, their fecal samples from individual mouse were collected and kept at -
80°C immediately for further analysis. The animal protocol was approved by the University of 
Georgia Institutional Animal Care and Use Committee. 
2.2.2 16S rRNA gene sequencing  
16S rRNA gene sequencing was performed as described (Lu et al., 2014). DNA was 
isolated from fecal pellets of individual mouse using PowerSoil® DNA isolation kit according to 
the manufacturer’s instruction. And then the DNA was amplified using 515F and 806R primers 
(Caporaso et al., 2012) targeting the V4 regions of 16S rRNA of bacteria, followed by 
normalization, barcoding procedure and finally was pooled to construct the sequencing library. 
The resultant DNA was quantified using Qubit 2.0 Fluorometer, and then sequenced using 
Illumina MiSeq (500 cycles v2 kit) in the Georgia Genomics Facility of University of Georgia. 
Paired-reads were assembled using Geneious software (Biomatters, Auckland, New Zealand), 
and operational taxonomic unit (OTU) picking and diversity analysis was conducted using 
Quantitative Insights into Microbial Ecology (QIIME) software. 
2.2.3 Shotgun metagenomics sequencing  
Shotgun metagenomics sequencing was performed as described (Gao, Bian, Mahbub, et 
al., 2017). DNA (10 ng/μL) of an individual mouse was fragmented using the Bioruptor UCD-
300 sonication device, then the library was constructed using the Kapa Hyper Prep Kit according 
to the manufacturer’s instruction. The resultant DNA was quantified using Qubit 2.0 
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Fluorometer, and then sequenced using an Illumina NextSeq High Output Flow Cell in the 
Georgia Genomics Facility of University of Georgia. Raw sequencing data were uploaded into 
the MG-RAST (Meta Genome Rapid Annotation using Subsystem Technology, version 3.6) for 
automated taxonomic and functional profiling with RefSeq and Subsystems databases, 
respectively (Meyer et al., 2008). A p-value < 0.05 was considered indicative of a significant 
difference between two groups. 
2.2.4 Statistical analysis of data 
Principle coordinate analysis (PCoA) was applied to differentiate the gut microbiome 
profiles between control and treatment samples, which examines the difference of beta diversity 
based on the UniFrac distance metric (Lozupone & Knight, 2005). Also, we used the Jackknifed 
beta diversity and hierarchical clustering analysis via Unweighted Pair Group Method with 
Arithmetic Mean (UPGMA) to compare the gut microbiome profiles between the control and 
treatment group. Moreover, the difference of gut microbial composition was assessed by a 
nonparametric test via Metastats software (http://metastats.cbcb.umd.edu/) as described 
previously (White, Nagarajan, & Pop, 2009). The metagenomic sequence count data for 
taxonomic analysis were processed using DESeq2 for statistics analysis (Love, Huber, & Anders, 
2014). 
2.3 Results 
The AIN-76A diet and BRB diet (formulated on AIN-76A with 10% BRB powder) used 
in the present study were also used in previous studies for the potential chemopreventive agents 
in BRB, for instance, simple and complex phenols or sterols (Stoner, 2009). It has been reported 
that the BRB diet is able to ameliorate ulcerative colitis and esophageal tumorigenesis in animal 
models (Kresty et al., 2001; Montrose et al., 2010). However, the functional effects of the BRB 
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diet on the gut microbiome has not been examined. With an increasingly strong link between the 
gut microbiome and human health, characterization of the functional changes driven by the BRB 
diet in the gut microbiome may provide mechanistic insights regarding the effects by black 
raspberries on host health and disease. In addition, oligofructose and polyphenols are both 
important components in berry fruits. Administration of oligofructose and dietary polyphenols 
can boost the A. muciniphila population in mice (Everard et al., 2011; Roopchand et al., 2015), 
so it is expected to see boosted A. muciniphila after the BRB diet treatment. 
2.3.1 The composition and diversity of mouse gut microbial communities were strikingly 
impacted following consumption of a BRB-rich diet  
Taxonomic summary bar plots (Figure 2.1A&S1) shows the identified gut bacteria 
assigned at the phylum level from 16S rRNA sequencing reads, with each color representing a 
bacterial phylum. The abundance of several bacterial phyla and the general composition of 
mouse gut microbiota were distinctly different between the control and BRB diet groups. In the 
control group, Firmicutes (83.41±5.97%) and Bacteroidetes (9.49±4.24%) covered the majority 
of the mouse gut microbes, followed by Actinobacteria (2.00±1.09%), Tenericutes 
(0.12±0.13%), Verrucomicrobia (<0.01%) and Proteobacteria (<0.01%). In contrast, in the BRB 
group, the abundance of the Firmicutes was reduced to 29.68±9.92%, whereas the Bacteroidetes 
was increased to 17.18±3.79%. This notable ratio change of Firmicutes to Bacteroidetes is 
consistent with the previous study that lower Firmicutes and higher Bacteroidetes were observed 
in lean subjects.(Turnbaugh et al., 2006) Other significantly altered bacterial phyla found in the 
gut microbiota of BRB-fed mice were Actinobacteria (1.68±0.69%), Tenericutes (0.18±0.17%), 
and Proteobacteria (<0.01%). In particular, the abundance of Verrucomicrobia (50.50±10.65%) 
was remarkably higher compared to the control group. The jackknifed beta diversity and 
hierarchical clustering analysis via the unweighted pair group method with arithmetic mean 
41 
(UPGMA) (Figure 2.1B) indicated that the control and BRB diet groups were typically clustered 
into their groups. Consistently, 3D principal coordinate analysis (PCoA) plot (Figure 2.1C) 
shows that the structure of gut microbial community is distinct from each other. The control and 
BRB group were well-separated and clustered together in their distinct groups. 89.83%, 3.81% 
and 1.92% variation were explained by principle component (PC) 1, PC2 and PC3, respectively. 
In addition, Figure S2 shows the gut bacterial genera that were altered significantly after BRB 
diet treatment compared to controls (p<0.05). There were 17 altered genera in total, with 7 
increased and 10 decreased genera. Interestingly, all 10 decreased bacterial genera were from 
Phylum Firmicutes, whereas 2 genera from Phylum Bacteroidetes significantly increased, which 
is consistent with a decreased Firmicutes/Bacteroidetes ratio. 
 
Figure 2.1 (A) The gut microbial composition at phylum level in the BRB diet and control 
groups, with each color representing one phylum. (B) Hierachical clustering analysis by UPGMA 
with the UPGMA distance tree constructed at a distance of 0.1. (C) 3D PCoA plot, based on the 
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UniFrac distance metric and beta diversity, shows that the BRB diet and control group are well 
separated. 
2.3.2 Highly-enriched A. muciniphila population and functional metagenome comparison  
As hypothesized, the normalized gene counts show that the A. muciniphila population in 
the mouse gut microbiome increased by approximately 157-fold in the BRB group compared to 
control (Figure 2.2A). Furthermore, the gut-microbiome related functions have been profoundly 
altered by BRB supported by the gut bacterial metagenome comparisons. Figure 2.2B shows that 
several metabolic subsystems at Level 1 of the SEED subsystem were significantly changed in 
the mouse gut microbiome, including photosynthesis, potassium metabolism, secondary 
metabolism and sulfur metabolism. In particular, bacterial functions related to the biosynthesis of 
vitamins and aromatic amino acids exhibited significant enrichment. Carbohydrate metabolism, 
especially sugar alcohol and di- and oligo-saccharide utilization was also significantly changed. 
In addition, several bacterial genes encoding antioxidative enzymes as well as programmed cell 
death (PCD) proteins were shifted between the control and BRB diet group. 
 
Figure 2.2 (A) The comparison of Akkermansia muciniphila population between control and 
BRB diet groups. (B) Comparative metagenomic analysis at the Level 1 SEED subsystem with 
photosynthesis, potassium metabolism, secondary metabolic and sulfur metabolism being 
significantly altered by BRB treatment. (p<0.05) 
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2.3.3 Enrichment of genes involved in vitamin synthesis 
The gut microbiome is an important source of vitamins (especially vitamin B and K) that 
are essential to human health (LeBlanc et al., 2013). In this study, we discovered a significant 
enrichment of the bacterial genes encoding key enzymes involved in the pathways of vitamin 
synthesis. Figure 2.3 displays the abundance distribution of genes involved in the biosynthetic 
pathways of riboflavin, folate and vitamin K. The relative abundances of GTP cyclohydrolase II 
and 3, 4-dihydroxy-2-butanone 4-phosphate synthase, which are rate-limiting enzymes in 
riboflavin synthesis (Hümbelin et al., 1999), significantly increased in the BRB diet group 
compared to controls. Likewise, a series of genes encoding enzymes involved in the biosynthesis 
of folate and vitamin K (phylloquinone and menaquinone) were also significantly enriched 
(p<0.05). Besides these, the relative abundances of bacterial genes of the biosynthesis of other 
vitamins or cofactors such as vitamin B1 (thiamin-phosphate pyrophosphorylase), pterin 
(dihydropteridine reductase) and lipoic acid (lipoate synthase) were all significantly enriched in 
the BRB diet group compared to controls (Figure 2.3). 
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Figure 2.3 Enrichment of gut bacterial genes involved in vitamin biosynthesis in the gut 
microbiome of mice fed on the BRB diet. (all comparisons listed are statistically significant, 
p<0.05) 
2.3.4 Enrichment of genes involved in aromatic amino acid synthesis 
We next looked into the gut bacterial synthesis of amino acids. The metabolism of 
aromatic amino acid was significantly enriched with BRB diet treatment. The synthesis of 
45 
chorismate, an important precursor for aromatic amino acids, was elevated with multiple genes 
encoding its biosynthetic enzymes being enriched (Figure 2.4). Likewise, the relative abundances 
of bacterial genes encoding enzymes involved in the biosynthesis of phenylalanine and tyrosine 
significantly increased. In addition, the biosynthesis of tryptophan, which is an essential amino 
acid, was also enriched in the BRB diet group. Specifically, the bacterial gene encoding the beta 
subunit of tryptophan synthase that catalyzes the last two steps in tryptophan biosynthesis was 
enhanced (Raboni, Bettati, & Mozzarelli, 2009). In addition, the relative abundances of genes 
encoding tryptophan-biosynthetic enzymes such as anthranilate phosphoribosyltransferase, 
indole-3-glycerol-phosphate synthase, anthranilate synthase and phosphoribosylanthranilate 
isomerase were all significantly elevated. 
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Figure 2.4 Enrichment of gut bacterial genes involved in aromatic amino acid metabolism in the 
gut microbiome of mice fed on the BRB diet. (All comparisons listed are statistically significant, 
p<0.05) 
2.3.5 BRB decreased bacterial gene involved in sugar alcohol and di- and oligo-saccharide 
utilization 
A significant decrease in the abundance of genes involved in sugar alcohol and di- and 
oligo-saccharide utilization was found in mouse gut microbiome of the BRB diet group 
compared to the control. Specifically, for sugar alcohols, the utilization of propanediol, 
ethanolamine, glycerol and glycerol-3-phosphate, and mannitol decreased (Figure 2.5). 
Meanwhile, for di- and oligo-saccharides, the utilization of trehalose, fructooligosaccharides and 
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raffinose, sucrose, lactose and galactose also significantly decreased (Figure 2.6). This obvious 
reduction in sugar alcohol and di- and oligo-saccharide utilization indicated significant 
downregulation in an extensive repertoire of gut bacterial genes involved in the utilization of a 
variety of sugars and might influence the carbohydrate metabolism and energy extraction 
efficiency in gut microbiota. 
 
Figure 2.5 Reduction of gut bacterial genes involved in sugar alcohol utilization in the gut 




Figure 2.6 Reduction of gut bacterial genes involved in di- and oligo-saccharide utilization in the 
gut microbiome of mice fed on the BRB diet. (all comparisons listed are statistically significant, 
p<0.05) 
2.3.6 Enrichment of genes encoding antioxidative enzymes and reduced programmed cell 
death (PCD) 
We compared several genes encoding antioxidative enzymes in gut bacteria between the 
BRB diet and control group. As shown in Figure 2.7A, the relative abundances of catalase, 
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cytochrome c551 peroxidase, and superoxide dismutase (Fe) were significantly upregulated in 
the BRB group compared to the control. In addition, the relative abundances of PCD system 
toxin genes mazF and ydcE decreased in the BRB diet, whereas antitoxin genes mazE and ydcD 
did not show significant difference (Figure 2.7B). Toxin-antitoxin systems are the most studied 
forms of PCD in bacteria. For example, the mazEF module found in E. coli is a typical toxin-
antitoxin system that triggers PCD (Engelberg-Kulka, Amitai, Kolodkin-Gal, & Hazan, 2006). 
The mazEF system comprises two adjacent genes mazE and mazF, encoding a antitoxin and an 
toxin, respectively.(Aizenman, Engelberg-Kulka, & Glaser, 1996) The mediation of the mazEF 
system could trigger PCD under conditions such as oxidative stress (Hazan, Sat, & Engelberg-
Kulka, 2004). Meanwhile, the ydcDE system found in B. subtilis is very similar to the mazEF 
system with ydcD and ydcE encoding an antitoxin and a toxin respectively (Pellegrini, Mathy, 
Gogos, Shapiro, & Condon, 2005). Together, these data indicate that the anti-oxidative capacity 
of the gut bacteria was reinforced and the progress of PCD was inhibited. 
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Figure 2.7 The distribution of gut bacterial genes encoding antioxidative enzymes (A, all 
comparisons listed are statistically significant, p<0.05) and genes involved in programmed cell 
death. (B) 
2.4 Discussion 
Mounting evidence shows that host health and susceptibility to diseases can be greatly 
influenced by the developmental trajectory of the gut bacteria, including alterations of the 
microorganisms and their collective genomes (Nicholson et al., 2012). To improve the host 
fitness through effective modulation of the gut microbiome is of importance for the protection 
from metabolic disorders associated with dysbiosis. Therefore, it is imperative to develop an 
effective approach by which we can directionally modify the gut microbiota, particularly its 
associated functions. In this study, we used high-throughput 16S rRNA gene sequencing and 
shotgun metagenomics gene sequencing to investigate the effects of a simple approach for the 
modulation of gut microbiome with a BRB-rich diet. The results clearly demonstrated that the 
structure of the mouse gut microbial community changed by the BRB diet treatment with 
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enriched A. muciniphila population, more importantly, the gut microbial metagenome 
experienced significant changes that could potentially confer benefits for the host by altering 
bacterial metabolic functions. These findings supported our hypothesis that BRB is able to 
modulate mouse gut microbiome probably by inducing A. muciniphila population and may 
provide novel insights regarding the gut microbiome as a therapeutic target to develop new and 
effective approaches to cope with gut microbiome-related adverse outcomes. 
An easily-accessed freeze-dried black raspberry-supplemented diet was used to 
selectively increase A. muciniphila, hence modulating the mouse gut microbiome. This selection 
is grounded in the fact that BRB is associated with many beneficial health effects, and more 
importantly, the abundance of A. muciniphila can be potentially boosted by BRB. Specifically, 
after 7-week BRB diet treatment, we identified a notable increase of A. muciniphila by 157-fold 
compared to controls. In addition, the functional metagenome profiles were also significantly 
changed after the BRB diet treatment, with metabolic alterations in bacterial pathways involved 
in vitamin synthesis, aromatic amino acid synthesis, carbohydrate utilization and oxidative stress, 
indicating that the BRB diet not only induced alterations in the gut microbiota at the abundance 
level but also had a profound impact on its metabolic functions. 
It is previously reported that obesity is associated with the ratio of Firmicutes to 
Bacteroidetes. In particular, the abundance of Bacteroidetes is lower, whereas the abundance of 
Firmicutes is higher in obese than lean subjects (Turnbaugh et al., 2006). The compositional 
pattern of gut microbiota in mice fed with BRB diet is opposite to that observed in obesity. The 
ratio of Firmicutes to Bacteroidetes is lower in the BRB group compared to controls. Likewise, it 
is previously reported that the A. muciniphila population decreased in obese children and 
increased after weight loss, and was negatively correlated with BMI (Escobar, Klotz, Valdes, & 
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Agudelo, 2014; Karlsson et al., 2012; Remely et al., 2015). In the present study, the A. 
muciniphila population was highly induced by BRB. Along with the progress of obesity, besides 
a characteristic bacterial compositional pattern, a series of metabolic disorders such as diabetes 
and metabolic syndrome would ensue (Badman & Flier, 2007), suggesting an association 
between the changing trajectory of gut bacteria and the deterioration of metabolic disorders. 
Thus, it is likely that the risk of development of metabolic disorders could be modulated by the 
gut microbiome and its functional reprogramming. The abundance of Firmicutes decreased while 
Bacteroidetes increased in mice fed with then BRB diet in the present study may imply less 
susceptibility for metabolic disorders. In addition, it is suggested recently that the gut 
microbiome plays an important role in the development of obesity through its capacity for energy 
harvest from the diet (Turnbaugh et al., 2006). Carbohydrate utilization is considered to be 
involved in the energy metabolism of the gut microbiota hence affecting its efficiency of energy 
extraction. After the BRB diet treatment, we discovered a major decrease in carbohydrate 
utilization especially sugar alcohols and di- and oligo-saccharides in mouse gut microbiome, 
which indicated altered efficiency in bacterial energy extraction and carbohydrate utilization 
strategy. Therefore, BRB may have the potential to protect the host from metabolic deterioration 
by steering the developmental trajectory of gut microbiota in a direction opposite to that in 
obesity. 
Gut microbiome modulation by BRB can benefit the host health through enhanced 
bacterial biosynthesis of important biomolecules such as vitamins and essential amino acids. 
These biomolecules play an indispensable role in maintaining cellular functions of the host; 
however most of them cannot be synthesized by human body (Drouin, Godin, & Pagé, 2011). 
Therefore the deficiency or even sub-optimal levels would inevitably result in health problems 
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(Said, 2011). In this study, we discovered that the abundance of multiple bacterial genes 
encoding key enzymes involved in biosynthesis of vitamin K, riboflavin, and folate were 
significantly upregulated in the BRB diet group. Modulation of the gut microbiome could be a 
novel approach to optimize the body level of vitamins. For example, sufficient body levels of 
folate would prevent neural tube defects (Said, 2011), and folate can be obtained via the gut 
bacterial biosynthesis. Likewise, a recent study suggested that besides vitamin D, vitamin K can 
also improve health by conferring protective effects on cardiovascular and skeletal system hence 
decreasing osteoporosis risk (O'Keefe et al., 2016). The gut microbiome exerts impact not only 
within the gastrointestinal tract but also on bone health manifested the idea that a series of host-
microbe metabolic axes connect the gut microbiome and distant organs such as liver, bone and 
brain via metabolic interactions (Nicholson et al., 2012). In addition, bacterial genes involved in 
tryptophan synthesis also showed significant enrichment. As an essential amino acid, tryptophan 
is linked to the regulation of food intake, mood disorders and immune responses (Le Floc’h, 
Otten, & Merlot, 2011). Clearly, improved bacterial production of vital biomolecules would 
confer health effects, thus, these findings may provide new insights regarding the micronutrient 
supplement via gut microbiome modulation. 
As expected, highly-enriched A. muciniphila population (157-fold compared to controls) 
was induced by BRB in the mouse gut microbiota, far more than its usual constitution in mouse 
cecal microbial community (Derrien et al., 2011). A. muciniphila was first described as a new 
strain with mucin-degrading ability in 2004 and has been linked to human health ever since 
(Derrien, Vaughan, Plugge, & de Vos, 2004). For example, increased expression of genes 
involved in immune response was shown in mice with colonization of A. muciniphila (Derrien et 
al., 2011). Likewise, the abundance of A. muciniphila is negatively correlated with body weight 
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and type 1 diabetes in human and mice (Amandine Everard & Cani, 2013). In the present study, 
we achieved a remarkable A. muciniphila increase in mice fed with the BRB diet. As a typical 
mucin-degrading bacterium, A. muciniphila is capable of using mucin as carbon, nitrogen and 
energy sources (Derrien et al., 2004). And in the epithelial tissue of intestine, goblet cells are 
responsible for the major mucin production (Linden, Sutton, Karlsson, Korolik, & McGuckin, 
2008). Previous studies showed that the number of goblet cells and the thickness of mucosal 
tissue increased in rats fed with oligofructose (Kleessen, Hartmann, & Blaut, 2003). Therefore, 
oligofructose, commonly found in berry fruits (Muir et al., 2007), may be the key factor for the 
increase of A. muciniphila for its capability to induce mucin production. The hypothesis is 
supported by the study in which administration of oligofructose increased the A. muciniphila 
population ~100 times, which is comparable to the present study (Amandine Everard et al., 
2011). Another study enumerated mycolytic bacteria in inflammatory bowel disease (IBD) 
patients and discovered that A. muciniphila decreased whereas another two mucolytic bacteria 
Ruminococcus gnavus and Ruminococcus torques increased (Png et al., 2010). In the present 
study, the BRB diet group showed an increase of A. muciniphila and decrease of Ruminococcus 
(Figure S2). In addition, lower levels of A. muciniphila population was recognized in patients 
with metabolic disorders (Derrien et al., 2017). Increased A. muciniphila is also associated with 
decreased inflammation in mice (Anhê et al., 2015). Given the anti-obesity and anti-diabetes 
functions of A. muciniphila, modulation of gut bacteria by increasing A. muciniphila abundance 
may attenuate or even eliminate metabolic disorders. 
As demonstrated above, the mouse gut microbiome was substantially changed by BRB at 
both compositional and functional levels, with a range of potential beneficial effects resulting 
from bacterial metabolic alterations. Many studies focused on the perturbation and dysfunction 
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of the gut microbiome caused by environmental stress or imbalanced diets. However, a better 
comprehension of the host-gut microbiome interactions would lead us to therapeutic strategies 
via desirable modulation of gut bacterial metabolism. The BRB diet used in this study to 
modulate the mouse gut microbiome is only a pilot example that the gut bacteria can be shaped 
and optimized for human health. More importantly, we demonstrated that it is of promise to 
improve host health through the interplay between the gut microbiome and host via effective 
interventions, although answers to the underlying mechanisms of the gut microbiome changes as 
well as the realization of precise manipulation of gut bacterial functions await future studies. 
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CHAPTER 3 – METABOLITE PROFILING OF THE GUT MICROBIOME IN MICE 
WITH DIETARY ADMINISTRATION OF BLACK RASPBERRIES 
3.1 Introduction 
The significance of the gut microbiota has been tremendously recognized over the past 
decade. Accumulating evidence suggested that the metabolic activities in the gut microbiome are 
profoundly intertwined with human health and disease (Nicholson et al., 2012). Maintaining a 
well-balanced gut microbiome is essential to host fitness; and perturbation in the gut microbial 
communities can lead to a series of adverse health outcomes (Claus, Guillou, & Ellero-Simatos, 
2016; Tremaroli & Bäckhed, 2012). The metabolic process of dietary precursors by the gut 
bacteria produces a spectrum of functional metabolites, through which the gut microbiota 
communicate with the host (Nicholson et al., 2012; Sharon et al., 2014). A variety of bacterial 
metabolites are beneficial. For example, the gut microbiome is an important source of vitamins 
such as vitamin B family and vitamin K (LeBlanc et al., 2013). Meanwhile, the fermentation of 
dietary fiber produces short-chain fatty acids (SCFAs) that can act as signaling molecules in 
diverse pathways and physiological functions (Smith et al., 2013; Tremaroli & Bäckhed, 2012). 
Butyrate regulates energy homeostasis and adiposity of the host through stimulating the secretion 
of glucagon-like peptide-1 (GLP-1) in intestinal enteroendocrine L cells and inducing leptin 
production in adipocytes (Samuel et al., 2008). However, undesirable metabolites can also be 
produced by the gut microbiota. A typical example is trimethylamine (TMA). The gut bacteria 
can convert dietary choline and carnitine into TMA (Koeth et al., 2013; Z. Wang et al., 2011). 
TMA is further metabolized to trimethylamine N-oxide (TMAO) in liver, which is associated 
with cardiovascular disease and chronic kidney disease (Tang et al., 2015; Z. Wang et al., 2011). 
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Thus, the functionality of the gut microbiome and its role in human health and disease is largely 
established by the metabolite profile. 
Consumption of berries including raspberries, cranberries and currants has diverse health 
benefits, such as antioxidant, anti-inflammatory and anti-carcinogenic effects (Beattie, Crozier, 
& Duthie, 2005; Paredes-López, Cervantes-Ceja, Vigna-Pérez, & Hernández-Pérez, 2010). A 
standardized black raspberry (BRB)-rich diet has been used to explore the functional role of 
BRB in a number of previous studies (Stoner, 2009). For example, recent studies clearly 
demonstrated the anti-carcinogenic effects of the BRB diet on esophageal and oral cancer (Chen, 
Rose, Hwang, Nines, & Stoner, 2006; Oghumu et al., 2017). The treatment of the BRB diet also 
inhibited colonic inflammation in an experimental model of colitis (Montrose et al., 2010). It is 
well accepted that the beneficial effects of berries are attributed to their abundant phytochemicals 
such as anthocyanins, flavonols, ellagitannins, and phenolic acids (Nile & Park, 2014; Seeram, 
2008). On the other hand, there is growing evidence that berries can modify the composition of 
the gut microbiota (Anhê et al., 2015; Bekiares, Krueger, Meudt, Shanmuganayagam, & Reed, 
2018; Tu et al., 2018). Given the pivotal role of the gut microbiota in human health coupled with 
the health benefits of berries, investigation of the microbiome changes associated with berry 
consumption may provide additional evidence regarding the underlying mechanisms of the 
beneficial health effects from berry consumption. In particular, several seminal studies have 
reported the connections between the gut microbiota and the health benefits of foodstuff. For 
instance, the health effects from the consumption of walnuts and almonds have been linked to the 
changes in the gut microbiota (Byerley et al., 2017; Holscher, Guetterman, et al., 2018; Holscher, 
Taylor, Swanson, Novotny, & Baer, 2018). 
We previously reported that dietary administration of BRB changed the composition and 
64 
diverse functional pathways in the mouse gut microbiome (Tu et al., 2018), which suggested the 
involvement of the gut microbial activities in the health effects of BRB. To further characterize 
the metabolic profile in the gut microbiome associated with BRB consumption, in the present 
study we combined untargeted and targeted metabolomics approaches to extensively profile the 
metabolome signatures of the gut microbiome. The results revealed a significantly distinct 
metabolite profile in the gut microbiome of mice fed BRB diet compared to mice fed control 
diet, with increased levels of a number of important metabolites such as tetrahydrobiopterin and 
butyrate that confer health benefits. We also conducted comprehensive analysis to integrate 
functional pathways and metabolic products. Specifically, increased levels of various vitamins 
and cofactors in concert with enrichment in their biosynthetic pathways were discovered in mice 
fed BRB diet, indicating that the differences in metabolite profiles could result from the BRB-
driven changes in bacterial metabolic pathways. This study further confirmed the role that the 
gut microbiome played in the beneficial health effects from BRB consumption, and provided a 
functional link among the functional foods, their health benefits and the gut microbiome. 
3.2 Materials and Methods 
3.2.1 Animals 
 Custom purified American Institute of Nutrition (AIN)-76A animal diet (Dyets, Inc., 
Bethlehem, PA, USA) was used as the control diet. BRB diet was prepared essentially as 
described (Tu et al., 2018). Briefly, whole ripe BRB (Rubus occidentalis) of the Jewel variety 
were freeze-dried and ground into powder. BRB powder was stored at −20°C until being 
incorporated into AIN-76A animal diet pellets by 10% w/w concentration at the expense of 
cornstarch. The diets were stored at 4°C until being fed to mice. Mice of control group were fed 
AIN-76A diet, mice of dietary treatment group were fed BRB diet. A total of 20 specific-
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pathogen free C57BL/6 mice (~8 week old), purchased from Jackson Laboratories, were housed 
in the animal facility of the University of Georgia for one week to acclimate with standard 
pelleted rodent diet and tap water ad libitum provided (protocol number: A2013 06-033-Y3-A3). 
In the beginning of the diet treatment, mice were randomly assigned to either control (AIN-76A 
diet) or treatment group (BRB diet). The environmental conditions were 22°C, 40–70% 
humidity, and a 12:12 hr light:dark cycle, and water ad libitum was provided throughout the 
experiment period. After 7 weeks, their fecal samples from individual mouse were collected and 
kept at -80°C immediately for further analysis. Regular monitoring for health conditions was 
twice a week. The animal protocol was approved by the University of Georgia Institutional 
Animal Care and Use Committee. 
3.2.2 Metagenomics sequencing 
 Shotgun metagenomic sequencing was performed as previously described (Chi et al., 2017). 
Briefly, fecal DNA (10 ng/μL) was fragmented using the Bioruptor UCD-300 sonication device. 
The Kapa Hyper Prep Kit was used for the construction of the sequencing library according to 
manufacturer’s instructions. The DNA was quantified using Qubit 2.0 Fluorometer. The 
sequencing was performed using the Illumina NextSeq High Output Flow Cell (300 Cycles; 
PE150) in the Georgia Genomics Facility of University of Georgia. For bioinformatics analysis, 
the MG-RAST metagenomics analysis sever (http://metagenomics.anl.gov, version 4.0.3) was 
applied for automatic functional pathway analysis of metagenomes using the Subsystems 
database (Keegan, Glass, & Meyer, 2016).  
3.2.3 Untargeted metabolomics profiling 
20 mg fecal sample and 50 mg glass beads (Sigma-Aldrich, MO) were added to 400 μL 
cooled methanol solution (methanol: water, 1: 1), followed by homogenizing using a 
66 
TissueLyser (Qiagen, Hilden, Germany) at 50 Hz for 10 min. The supernatant was collected after 
centrifuging for 10 min at 12,000 rpm, and dried by vacuum centrifugation in a Savant Speed-
Vac concentrator (Thermo Scientific, Waltham, MA), and then resuspended for injection. The 
mass spectrometer was interfaced with an Agilent 1290 Infinity II UPLC system. LC-MS 
analysis was performed on a quadrupole-time-of-flight (Q-TOF) 6530 mass spectrometer 
(Agilent Technologies, Santa Clara, CA) with an electrospray ionization source. Metabolic 
features were analyzed in the positive mode over a m/z range of 50-1000 with a C18 T3 reverse-
phased column (Waters Corporation, Milford, MA). The XCMS Online sever 
(https://xcmsonline.scripps.edu, version 3.5.1) was applied for peak picking, alignment, 
integration, and extraction of the peak intensities. MS/MS data were generated on the Q-TOF for 
the identification of differentiated molecular features. The softwares of MS-DIAL (version 2.90) 
(Tsugawa et al., 2015) and MS-FINDER (version 2.40) (Tsugawa et al., 2016) were used for the 
identification of metabolites based on the MS/MS spectrum. 
3.2.4 Quantification of fecal SCFAs 
SCFAs (acetate, butyrate and propionate) in fecal samples were quantified as previously 
described (Zheng et al., 2013). Briefly, sample aliquots were added to NaOH solution (0.005 M) 
containing internal standards (50 µg/mL of acetic acid-d4, 10 µg/mL of propionic acid-d2, and 
10 µg/mL of butyric acid-d2), followed by homogenization and centrifugation. The supernatant 
were transferred, and subsequently added a mixture of 1-propanol:pyridine (3:2, v/v) and propyl 
chloroformate for derivatization. After sonication, the propyl formate derivatives were extracted 
using hexane, and then transferred to an autosampler vial for injection. An Agilent 7820A GC-
5977B MS system (Santa Clara, CA) coupled with an Agilent DB-5 column (30m x 0.25mm x 
0.25 μm) was used for GC/MS analysis. 
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3.2.5 Statistical analysis of data 
PCA and hierarchical clustering algorithm were used to visualize the comparison of 
metabolite profiles. Two-tailed Welch’s t-test was used to analyze metabolites that differed in 
abundance between groups corrected for the FDR. The metagenomics sequence count data for 
functional analysis were processed using DESeq2(Love, Huber, & Anders, 2014) for statistics 
analysis adjusted for multiple testing of FDR. The correlation matrix between bacterial pathways 
and metabolites was generated using Pearson’s correlation coefficient. Statistical significances of 
SCFAs between two diet groups were assessed by Student t test. 
3.3 Results 
3.3.1 Experimental workflow 
We used a mouse model and a standardized BRB-rich diet to study the metabolic profile 
in mouse gut microbiome with the consumption of BRB. The formula of the BRB diet used in 
the present study has been used in a series of previous studies (Stoner, 2009). Fecal samples were 
collected after 7 weeks of diet treatment to represent the mouse gut microbial contents. Figure 
3.1A summarizes the experimental workflow. We combined untargeted and targeted 
metabolomics to exhaustively probe gut microbiota-derived metabolites. LC-ESI-TOF was used 
to conduct untargeted metabolomics and MS/MS spectra were generated to confirm the 
metabolite identities. GC/MS was used for the targeted analysis of SCFAs. We also integrated 
metagenomics and metabolomics to map the changes in metabolic pathways and products. 
Figure 3.1B summarizes the main point of the present study. 7 weeks of BRB diet 
treatment substantially changed the metabolic functions of the mouse gut microbiome. The heat 
map (Figure 3.1B, upper right) constructed by comparative metagenome analysis shows a 
consistent clustering pattern within respective diet groups, indicating a considerably 
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differentiated functional pathway assembly. More importantly, alterations in microbial metabolic 
pathways together with unique precursors in BRB lead to significant metabolic changes as 
shown in the cloud plot (Figure 3.1B, lower right), which may contribute to the underlying 
mechanisms of the beneficial health effects of BRB consumption. 
 
Figure 3.1 Experimental workflow including pathway analysis and metabolite profiling (A); 
microbiome changes in functional pathways and metabolites driven by BRB consumption, 
together with unique precursors in BRB contribute to the health benefits from BRB consumption 
69 
(B). 
3.3.2 BRB consumption differentiated gut microbiome metabolite profile revealed by 
untargeted metabolomics 
Metabolomics profiling enables us to assess the changes of metabolites in the gut 
microbiome. As shown in figure 3.2A, the hierarchical clustering heat map constructed using 
significantly-changed molecular features shows a consistent clustering pattern within individual 
groups. Figure 3.2B also illustrates that the BRB-fed group is well separated from the control 
diet group by PCA analysis. We have identified 54 microbiome metabolites that were 
differentiated by BRB consumption in the gut microbiome (Table S1), for instance, vitamin-
related compounds, amino acid derivatives, dipeptides and natural products. Together the data 
indicate that the metabolite profiles of these two diet groups are readily differentiated with 
diverse bacterial metabolites being directly produced or modified by the gut microbiota. 
 
Figure 3.2 Heat map constructed using molecular features shows that BRB consumption 
significantly changed the metabolite profile in the gut microbiome (A); fecal metabolite profiles 
of mice fed BRB were well separated from mice fed control diet by PCA (B). 
3.3.3 Elevated levels of vitamins and cofactors in the gut microbiome of mice fed BRB diet 
Enrichment in vitamin-related metabolites together with increases in their synthetic 
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pathways were found in mice of BRB diet compared to mice of control diet (Figure 3.3). 
Metabolites that have vitamin E antioxidant activity including tocopherols and tocotrienols were 
found to have higher levels in mice from BRB diet group (Figure 3.3A, B&C). Since tocopherols 
and tocotrienols are usually found in plants and not synthesized by bacteria (Fritsche, Wang, & 
Jung, 2017; Sen, Khanna, & Roy, 2006), the increased abundances of tocopherols and 
tocotrienols probably came from BRB per se. Moreover, we observed that tetrahydrobiopterin, a 
cofactor of multiple important biological reactions, increased 1000-fold in mice fed BRB (Figure 
3.3D). The pathway of pterin biosynthesis, which is responsible for the biosynthesis of 
tetrahydrobiopterin, also shows a 7-fold increase (Figure 3.3E). Likewise, menaquinone-1, which 
belongs to vitamin K2 family, increased approximately 4-fold in mice fed BRB (Figure 3.3G). 
Gut bacteria are known as important producers of vitamins, and menaquinones can be obtained 
from the gut bacteria (LeBlanc et al., 2013). Accordingly, the bacterial pathway synthesizing 
menaquinones is significantly enriched (Figure 3.3H). Additionally, to explore the functional 
correlation between the changes in metabolic pathways and corresponding metabolites, we 
conducted functional correlation by calculating the Pearson’s correlation coefficient. Clear 
correlations could be identified between the synthetic pathway abundances and metabolite 
intensities of tetrahydrobiopterin (Figure 3.3F) and menaquinone-1 (Figure 3.3I) (rho > 0.5, p < 
0.05), suggesting that the increased levels of these metabolites resulted from BRB-driven 
elevation in related synthetic activities. These data suggest that the levels of various vitamins and 
cofactors are elevated in the gut microbiome of mice fed BRB, either from BRB per se or BRB-
driven changes in the gut microbiome. 
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Figure 3.3 BRB consumption significantly increased vitamin-related metabolites in the mouse 
gut microbiome, as exemplified by vitamin E metabolites (A, B&C), cofactor tetrahydrobiopterin 
(D) and menaquinone-1 (G); meanwhile, gut bacterial pathways involved in the biosynthesis of 
tetrahydrobiopterin (E) and menaquinone (H) were upregulated in mice fed BRB, which shows 
clear correlation with the abundances of corresponding metabolites (F, I) (p<0.05; rho>0.5). 
(***p<0.001; **p<0.01; *p<0.05) 
3.3.4 Functional metabolites that have beneficial health effects in the gut microbiome of 
mice fed BRB diet 
In addition to vitamins and cofactors, we also observed an enrichment of important 
metabolites that may confer health benefits in the gut microbiome of mice fed BRB diet 
compared to mice fed control diet (Figure 3.4). For instance, protocatechuic acid is a phenolic 
acid and it has distinct antioxidant and anti-inflammatory effects. Protocatechuic acid is a typical 
metabolite of polyphenols, which are abundant in BRB, therefore it is expected to observe a 900-
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fold increase of protocatechuic acid in mice fed BRB diet. Protocatechuic acid has many 
beneficial health effects that are recently reviewed (Kakkar & Bais, 2014). We also observed that 
alpha-linolenic acid (ALA) and its further metabolite stearidonic acid increased 3-fold and 11-
fold, respectively. Both of them are important fatty acids that are known to be abundant in berry 
fruits (Barceló-Coblijn & Murphy, 2009; Whelan, 2008). The abundance of oleoylethanolamine 
(OEA) increased more than 3-fold, which is an important signaling molecule as an endogenous 
peroxisome proliferator-activated receptor alpha (PPAR-α) agonist. OEA is involved in the 
regulation of satiety and bodyweight (Gaetani, Oveisi, & Piomelli, 2003; Verme et al., 2005). In 
addition, the abundance of kaempferol 3-sophorotrioside increased approximately 50-fold, which 
belongs to flavonoid glycosides. Flavonoid and derivatives are typical polyphenolic molecules 
rich in berry fruits, and kaempferol and its glycosides have many health effects such as 
antitumor, antioxidant and anti-inflammatory activities (Kim, Ku, Lee, & Bae, 2012; Wang et al., 
2018). 
 
Figure 3.4 Fecal metabolites that have beneficial health effects in the gut microbiome of mice fed 
BRB diet were enriched compared to mice fed control diet. (***p<0.001; **p<0.01; *p<0.05) 
3.3.5 BRB consumption changed the SCFAs in the gut microbiome 
SCFAs are important gut microbial products from microbial fermentation that have 
diverse biological functions. We examined the changes of SCFAs and found that the abundance 
of butyrate significantly increased in the gut microbiome of mice fed BRB diet compared to mice 
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fed control diet (Figure 3.5). The levels of acetate and propionate did not show significant 
differences between two groups. Butyrate exerts anti-inflammatory effects by inhibiting the 
release of cytokines and chemokines. Meanwhile, the expression of tight junction proteins can be 
improved by intestinal butyrate (Nicholson et al., 2012). Therefore, the increased levels of 
butyrate in the gut microbiome could contribute to associated health effects of BRB. 
 
Figure 3.5 Comparisons of SCFAs in the gut microbiome of mice fed BRB or control diets. 
(*p<0.05; N.S. not significant) 
3.4 Discussion 
Our previous study has clearly demonstrated the impact of BRB consumption on mouse 
gut microbiome at both compositional and functional levels (Tu et al., 2018). For example, BRB 
consumption changed multiple microbiome-related functional pathways including vitamin 
synthesis and carbohydrate metabolism (Tu et al., 2018). The effects of BRB on the functional 
pathways in gut bacteria, together with the interactions of gut bacterial activities to human health 
imply that BRB-driven microbiome changes may play a role in the health effects of BRB 
consumption. Meanwhile, changes in microbial metabolic pathways could lead to different 
metabolic products. To further investigate the functional profile of the gut microbiome 
associated with BRB consumption, in this follow-up study, we examined the metabolome 
differences in the gut microbiome of mice fed BRB diet compared to mice fed control diet. A 
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significantly distinct metabolite profile was observed representing a different functional role of 
the BRB-shaped gut microbiome. A large number of metabolites were significantly changed in 
the gut microbiome with BRB consumption. Database searching using exact masses coupled 
with tandem MS/MS analysis identified a number of metabolites that might account for the 
beneficial effects of BRB consumption. These findings may provide mechanistic insights 
regarding the gut microbial activities contributing to the health effects of BRB. 
Accumulating evidence suggested the importance of the gut microbiome in host health 
and disease (Cho & Blaser, 2012). The composition and functionality of the gut microbiome can 
be readily affected by various intrinsic and extrinsic factors (Sommer & Bäckhed, 2013). Among 
these factors, diet received considerable attention. On one hand, typical western diet that is rich 
in simple sugars and saturated fat is linked to increased risks of adverse health outcomes such as 
obesity, diabetes and cardiovascular disease, and the gut microbiome is believed to be involved 
in this progress (David et al., 2014; Turnbaugh et al., 2009). On the other hand, healthy dietary 
patterns such as Mediterranean diet beneficially impact the host via effects on the gut microbiota 
such as promoting bacteria that utilize dietary fiber and produce SCFAs (De Filippis et al., 
2016). In the present study, we focused on investigating the impact of a BRB-rich diet on the gut 
microbiota especially its metabolic profile for the exploration of the relationship between BRB 
and the gut microbiome. We observed consistent alterations in bacterial pathways and metabolic 
products driven by BRB consumption, suggesting that bacterial functions can be readily altered 
by dietary patterns leading to differential metabolic products, thereby differentially influencing 
the host. 
We previously reported that a number of bacterial genes encoding enzymes that are 
involved in vitamin and cofactor biosynthesis were enriched in the gut microbiome of mice fed 
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BRB (Tu et al., 2018). Accordingly, we observed increased levels of vitamins such as 
menaquinone-1 (vitamin K2 family) and important cofactor tetrahydrobiopterin in the fecal 
samples of mice with BRB consumption. However, aside from the contribution of the gut 
microbiota, it should be noted that vitamins are naturally present in berry fruits (Howard & 
Hager, 2007). We also observed a 1000-fold increase of tetrahydrobiopterin. Tetrahydrobiopterin 
is a crucial cofactor that participates in a series of biological reactions (Kappock & Caradonna, 
1996). One of them is converting aromatic amino acids into precursors of neurotransmitters such 
as serotonin and dopamine (Werner-Felmayer, Golderer, & Werner, 2002). Thus, the deficiency 
of tetrahydrobiopterin is associated with neurological disorders (Foxton, Land, & Heales, 2007). 
Moreover, insufficient tetrahydrobiopterin also causes reduced levels of nitric oxide, which 
contributes to insulin resistance (Wu & Meininger, 2009). Therefore, supplementation with 
tetrahydrobiopterin can prevent from neurological diseases and diabetes caused by 
tetrahydrobiopterin deficiency. In addition, it is reported that the gut microbiome is an 
exogenous source of tetrahydrobiopterin (Belik et al., 2017); and we discovered increased levels 
of tetrahydrobiopterin and its biosynthetic pathway in the gut microbiome of mice fed BRB. It is 
likely that BRB consumption enhances the gut bacterial activities on the production of 
tetrahydrobiopterin, which provides mechanistic insights regarding the neuroprotective and 
antidiabetic effects of BRB (Kirakosyan et al., 2018; Subash et al., 2014; Yang, Tian, Wu, Guo, 
& Lu, 2018). 
As important gut microbiome-derived metabolites, the functions of SCFAs have been 
extensively studied. For example, it is well documented that butyrate has anti-inflammatory 
activities primarily via the inhibition of nuclear factor κB (NF-κB) activation in human colonic 
epithelial cells (Inan et al., 2000; Segain et al., 2000). NF-κB regulates many cellular genes that 
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are involved in early immune inflammatory responses, and the activity of NF-κB is frequently 
perturbed in inflammatory bowel disease (IBD) (Schreiber, Nikolaus, & Hampe, 1998) and 
colorectal cancer (Lind et al., 2001). Butyrate therefore plays a protective role in these diseases 
(Canani et al., 2011). Meanwhile, it is demonstrated that BRB diet has effects against the 
development of colorectal cancer (Bi, Fang, Wang, Stoner, & Yang, 2010; L.-S. Wang et al., 
2011) and IBD (Montrose et al., 2010). Thus, increased levels of butyrate in the gut microbiome 
may be one of the underlying mechanisms of the anti-inflammatory and anti-cancer effects of the 
BRB diet. 
Diet is a key factor that influences the gut microbiome, meanwhile, the metabolic 
activities of the gut microbiota are also indispensable regarding the health benefits of functional 
foods (Zmora, Suez, & Elinav, 2018). The role of the gut microbiome in the toxicity of 
environmental toxic chemicals has been increasingly acknowledged, of equal importance, future 
studies on the role of the gut microbiome in the health benefits of various functional foods are 
warranted. 
In summary, we combined untargeted and targeted metabolomics to analyze the fecal 
samples of mice with administration of BRB. Metabolomic profiling revealed that BRB 
consumption drastically changed the metabolome of the mouse gut microbiome, with many 
metabolites contributing to the beneficial effects from BRB consumption. Taken together, these 
results indicate the involvement of the gut microbiome in the health benefits of BRB, and the 
connection among the functional foods, their health benefits and the gut microbiome. 
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CHAPTER 4 – MICROBIOME-DERIVED ARYL HYDROCARBON RECEPTOR 
LIGANDS AMELIORATE INTESTINAL INFLAMMATION IN MICE 
4.1 Introduction 
The gut microbiota is now well recognized for its critical functions in the immune 
system, metabolic processes and diverse signaling pathways (Kamada, Seo, Chen, & Núñez, 
2013; Nicholson et al., 2012; Round & Mazmanian, 2009; Tremaroli & Bäckhed, 2012). 
Mounting evidence indicated that an imbalanced gut microbiota is highly associated with various 
human diseases including inflammatory bowel disease (IBD), colorectal cancer, obesity, diabetes 
and neurological disorders (Louis, Hold, & Flint, 2014; Manichanh, Borruel, Casellas, & 
Guarner, 2012; Sampson et al., 2016; Tremaroli & Bäckhed, 2012; Turnbaugh et al., 2006). Even 
with an increasingly deeper understanding of the association between adverse health outcomes 
and gut microbial patterns, mechanistic insights into the direct communication and functional 
link between gut bacteria and host remain largely unexplored. Concurrently, gut microbiome-
derived specialized metabolites contribute in a significant way to host physiology (Sharon et al., 
2014; Tremaroli & Bäckhed, 2012). For example, bacterial metabolic products that are ligands to 
nuclear receptors including AHR lead to effects on gut immune cells and mucosal barrier 
(Hubbard et al., 2015; Lamas et al., 2016; Venkatesh et al., 2014). Thus, production of bacterial 
metabolites is an important factor for the health implications of the gut microbiota. 
Intestinal inflammation is involved in development of intestinal dysfunction including 
IBD. IBD, including Crohn's disease (CD) and ulcerative colitis (UC), is the complex 
inflammatory disorder of the digestive tract that usually involve an abnormal interaction between 
the immune system and gut microbes (Manichanh et al., 2012). In particular, the AHR 
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expression is significantly diminished in IBD patients (Monteleone et al., 2011), and the 
activation of AHR is shown to suppress inflammation in mice with experimental colitis (Goettel 
et al., 2016). AHR is a ligand-activated transcription factor that has a variety of endogenous and 
exogenous ligands (Nguyen & Bradfield, 2007; Stejskalova, Dvorak, & Pavek, 2011). 
Microbiome-derived metabolites are an important source of endogenous AHR ligands (Murray 
& Perdew, 2017). For example, tryptophan metabolites produced by gut bacteria such as indole-
3-acetate act as AHR ligands and play a protective role in intestinal homeostasis (Schiering et al., 
2017; Zelante et al., 2013). Together, these observations suggest the relevance of intestinal 
inflammatory status and health-promoting functions of the gut microbiome especially production 
of microbiome-derived AHR ligands. 
Given the functional role of AHR activation in intestinal inflammation, coupled with the 
production of AHR ligands by gut bacteria, modulating gut microbial activities on AHR ligand 
production is an attractive therapeutic target. In addition, diet is an essential factor that affects 
the functionality of the gut microbiome (Sonnenburg & Bäckhed, 2016). Particularly, a black 
raspberry (BRB)-rich diet has been shown to alleviate intestinal inflammation in experimental 
colitis and suppress colorectal cancer in mice and human (Montrose et al., 2010; Pan et al., 2015; 
Wang et al., 2010). In the present study, we used the BRB diet as an exemplary approach for 
BRB dietary intervention to investigate the mechanism underlying the effects on intestinal 
inflammation of BRB consumption through the lens of gut microbiota and its metabolites. We 
hypothesized that a global understanding of gut bacterial metabolites could yield insights into 
currently uncharacterized microbiome-derived AHR ligands that have potential to beneficially 
affect host health. We first validated the ameliorating effect on intestinal inflammation by the 
BRB dietary intervention in dextran sulfate sodium (DSS)-treated mice. We next examined the 
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commensal bacteria by 16S rRNA sequencing to investigate the perturbation and restoration in 
the gut microbial communities. Furthermore, we showed that the BRB diet-modulated gut 
microbiome had more abundant AHR ligands and bacterial genes involved in AHR ligand 
production. We identified two microbiome-derived AHR ligands, hemin and biliverdin, that are 
highly correlated with specific gut bacteria. Finally, we examined host metabolic profiles to 
investigate host responses to the interaction of intestinal inflammation and BRB dietary 
intervention. This study offered mechanistic insights regarding the effects of BRB dietary 
intervention on intestinal inflammation. More importantly, additional evidence was provided on 
the communications between the gut microbiota and host through production of microbiome-
derived AHR ligands. 
4.2 Materials and methods 
4.2.1 Study approval 
The study protocol (NO: A2013 06-033-Y3-A3) was approved by the University of 
Georgia Institutional Animal Care and Use Committee. All methods were performed in 
accordance with the relevant guidelines and regulations. All efforts were made to minimize 
animal suffering. 
4.2.2 Diet preparation 
Custom purified American Institute of Nutrition (AIN)-76A animal diet (Dyets, Inc., 
Bethlehem, PA, USA) was used as the control diet. BRB diet used for dietary intervention was 
prepared essentially as described (Oghumu et al., 2017). Briefly, whole ripe BRB (Rubus 
occidentalis) of the Jewel variety were freeze-dried and ground into powder. BRB powder was 
stored at −20°C until being incorporated into AIN-76A animal diet pellets by 10% w/w 
concentration at the expense of cornstarch. The diets were stored at 4°C until being fed to mice. 
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Mice of control diet groups were fed AIN-76A diet, mice of dietary intervention groups were fed 
BRB diet. The BRB diet used in the present study was previously used in a large number of 
studies for chemopreventive effects as well as microbiome modulation (Aiyer, Srinivasan, 
Gupta, & cancer, 2008; Casto et al., 2002; Harris et al., 2001; Kresty et al., 2001; G. D. Stoner et 
al., 2007; Tu et al., 2018). Its preparation was standardized to ensure consistency and 
reproducible results. All berries of a single variety were harvested from a single farm in Southern 
Ohio. Chemical characterization of 26 randomly-selected functional components including 
simple phenols and athocyanins has been conducted for standardization purposes, which together 
with further details regarding the BRB diet was previously discussed and reviewed (Stoner, 
2009). 
4.2.3 Mice 
Specific-pathogen-free C57BL/6 mice (8 weeks of age; Jackson Laboratories, Bar 
Harbor, ME) were housed in the animal facility of University of Georgia. Plain water and 
standard pelleted rodent diet ad libitum were provided for 1 week for their acclimation. The 
environmental conditions were maintained as 22°C temperature, 40–70% humidity, and a 12:12 
hour light:dark cycle. After 1 week of acclimation, the mice were then randomly assigned to 4 
groups (Figure 4.1a; AIN-76A, AIN-76A+DSS, BRB, BRB+DSS; n=10 per group). Their food 
was provided with AIN-76A or BRB diets accordingly. After 2 weeks of special diets, 1% DSS 
in drinking water was administered to mice of DSS treatment groups for another 2 weeks. 
Regular monitoring for health conditions was done twice a week. Fecal samples were collected 
individually before sacrifice; Plasma, cecal contents, and colon tissues were collected during 
necropsy and colon tissues were treated with RNAlater (Thermo Fisher Scientific). All samples 
were kept at -80°C until further analysis. The mice were treated humanely and with regard for 
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alleviation of suffering. 
4.2.4 Quantitative RT-PCR 
Colon RNA was extracted using RNeasy Mini kit (Qiagen, Valencia, CA) according to 
manufacturer’s instructions. Then RNA was processed with DNA-free™ DNA Removal Kit 
(Thermo Fisher Scientific) to remove DNA contamination. RNA quality and concentration were 
determined using an Agilent TapeStation (Agilent Technologies). Reverse transcription was 
performed with iScript™ Reverse Transcription Supermix (Bio-Rad Laboratories, CA) 
according to manufacturer’s instructions. qPCR was performed with the SsoAdvanced™ 
Universal SYBR® Green Supermix (Bio-Rad) and primers listed in Table (Table S2). The 
reactions were run on a Bio-Rad CFX96 Touch™ Real-Time PCR Detection System using the 
protocol as previously described (Bian et al., 2017). Results were analyzed by the ΔΔCt method 
of CFX manager software (Bio-Rad) using Gapdh as the internal control. 
4.2.5 16S rRNA gene sequencing and analysis 
16S rRNA gene sequencing was performed as previously described (Chi et al., 2017). 
Briefly, microbial DNA was extracted from mouse fecal pellets using PowerSoil DNA isolation 
kit according to manufacturer’s instructions. Then the DNA was amplified using 515 (5’-
GTGCCAGCMGCCGCGGTAA) and 806 (5’-GGACTACHVGGGTWTCTAAT) primers 
targeting the V4 regions of 16S rRNA gene in bacteria(Caporaso et al., 2012). Individual 
samples were normalized, barcoded and finally pooled for the construction of the sequencing 
library, then sequenced using the Illumina MiSeq (500 cycles v2 kit) in the Georgia Genomics 
Facility of University of Georgia. Paired reads were assembled using Geneious 8.15 (Biomatters, 
Auckland, New Zealand). Operational taxonomic unit (OTU) picking and diversity analysis were 
conducted using Quantitative Insights into Microbial Ecology (QIIME, version 1.9.1). 
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4.2.6 Reporter assay for AHR activation 
AHR activation was measured using a commercially available Reporter Assay System 
(INDIGO Biosciences, Inc., State College, PA). Mouse cecal samples were suspended in PBS 
(100mg/mL), centrifuged at 5,000 rpm for 15 min at 4 °C, and then filtered with 0.2 mm filters 
(VWR, Fontenay-sous-Bois, France) as described in the previously study (Lamas et al., 2016). 
Cecal extraction was diluted (1:10) with Compound Screening Medium (CSM) supplied in the 
reporter assay kit. Hemin and biliverdin hydrochloride (Sigma-Aldrich) were dissolved in 
DMSO and diluted with CSM to a concentration of 50 mM. Potent AHR agonist 2,3,7,8-
tetrachlorodibenzop-dioxin (TCDD) was used as the positive control. 
4.2.7 Metagenomics sequencing 
Shotgun metagenomic sequencing was performed as previously described (Chi et al., 
2017). Briefly, fecal DNA (10 ng/μL) was fragmented using the Bioruptor UCD-300 sonication 
device. The Kapa Hyper Prep Kit was applied to construct the sequencing library according to 
manufacturer’s instructions. The quantification of DNA was performed using the Qubit 2.0 
Fluorometer. The sequencing was performed using the Illumina NextSeq High Output Flow Cell 
(300 Cycles; PE150) in the Georgia Genomics Facility of University of Georgia. The MG-RAST 
metagenomics analysis sever (http://metagenomics.anl.gov, version 4.0.3) was applied for 
automatic functional analysis of metagenomes using the Subsystems database (Meyer et al., 
2008).  
4.2.8 Metabolomics profiling 
For fecal samples, 20 mg feces and 50 mg glass beads (Sigma-Aldrich, MO) were added 
to 400 μL cooled methanol solution (methanol: water 1: 1), followed by homogenizing using a 
TissueLyser (Qiagen) for 15 min at 50 Hz. The supernatant was collected after centrifuging for 
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10 min at 1,2000 rpm, and dried by vacuum centrifugation in a Savant Speed-Vac concentrator 
(Thermo Scientific, Waltham, MA), and then resuspended for injection. For plasma samples, 80 
µL cooled methanol was added to 20 µL plasma. After incubation for 30 min at -20°C, the 
samples were centrifuged for 10 min at 1,2000 rpm. The supernatant was collected after 
centrifuging for 10 min at 1,2000 rpm, dried up in a speed vacuum, and then resuspended. 
LC-MS analysis was performed on a quadrupole-time-of-flight (Q-TOF) 6550 mass 
spectrometer (Agilent Technologies, Santa Clara, CA) with an electrospray ionization source. 
The mass spectrometer was interfaced with an Agilent 1290 Infinity II UPLC system. 
Metabolites were analyzed in the positive mode over a m/z range of 50-1000 with a C18 T3 
reverse-phased column (Waters Corporation, Milford, MA). The XCMS Online sever 
(https://xcmsonline.scripps.edu, version 3.5.1) was applied for peak picking, alignment, 
integration, and extraction of the peak intensities. A two-tailed Welch’s t-test was used for the 
assessment of differentiated metabolite features. MS/MS data were generated on the Q-TOF for 
the identification of differentiated metabolites. The softwares of MS-DIAL (version 2.90) 
(Tsugawa et al., 2015) and MS-FINDER57 (version 2.40) (Tsugawa et al., 2016) were used for 
the identification of metabolites based on the MS/MS spectrum. 
4.2.9 Statistical analysis of data 
Unless otherwise indicated, all results are expressed as mean values with standard 
deviation (****p<0.0001; ***p<0.001; **p<0.01; *p<0.05; N.S. p>0.05). Statistical differences 
in gene expression of inflammatory markers were calculated by one-way ANOVA. Statistical 
differences in AHR activation were calculated by two-way ANOVA. Differences in gut bacterial 
abundances were assessed by a nonparametric test via Metastats (White, Nagarajan, & Pop, 
2009). Two-tailed Welch’s t-test was used to analyze metabolites that differed in abundance 
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between groups corrected for the FDR. The metagenomics sequence count data for functional 
analysis were processed using DESeq2 (Love, Huber, & Anders, 2014) for statistics analysis 
adjusted for multiple testing of FDR. Also, alpha rarefaction and PCoA were used to assess 
diversities in the gut microbial communities. PCA and hierarchical clustering algorithm were 
used to visualize the comparison of metabolite profiles. The correlation matrix between gut 
bacterial species and metabolites was generated using Pearson’s correlation coefficient. 
4.3 Results 
4.3.1 Ameliorating effect on intestinal inflammation by the BRB dietary intervention 
To determine the effects of BRB dietary intervention on intestinal inflammation, mice 
were given either AIN-76A diet (Control diet) or BRB diet (Control diet with 10% freeze-dried 
BRB powder) in addition to plain water for 2 weeks, and 1% DSS was then added to the drinking 
water of DSS-treated groups for another 2 weeks to induce intestinal inflammation as described 
in Fig. 4.1a. As shown in Fig. 4.1b, the expression of pro-inflammatory cytokines increased by 
DSS treatment and the effect was reversed by BRB diet. Specifically, DSS treatment 
significantly induced TNFα and iNOS expression in the colon tissue and the pro-inflammatory 
effects were significantly suppressed if concurrently given BRB diet; we also observed similar 
trends in the expression of IL-6 and IL-1β. The reversed expression of pro-inflammatory 
cytokines indicated the ameliorating effects by the BRB dietary intervention, which is consistent 
with the results of previous studies (Montrose et al., 2010). 
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Figure 4.1 Intestinal inflammatory levels of DSS-treated mice (AIN-76+DSS) were significantly 
higher than that of controls (AIN-76A), which was alleviated by BRB dietary intervention 
(BRB+DSS). a Experimental design; 40 mice were randomly assigned into 4 groups: AIN-76A, 
AIN-76A+DSS, BRB, BRB+DSS; mice from each group were fed the according diet, and 1% 
DSS was added in their drinking water for 2 weeks for mice with DSS treatment. b Gene 
expression of inflammatory markers, including TNFα, iNOS, IL-1β and IL-6 were significantly 
increased by DSS treatment and significantly reversed by BRB dietary intervention. (AIN-76A, 
n=5; AIN-76A+DSS, n=4; BRB+DSS, n=5; one-way ANOVA; **p<0.01 ****p<0.0001). 
4.3.2 Restoration of diversity and composition in gut microbial communities 
We analyzed 16S rRNA sequencing data to determine the alterations induced by DSS 
treatment in the gut microbial communities with or without BRB dietary intervention. Alpha 
diversities were measured and compared in the overall microbial community using observed 
OTUs, chao1 and PD whole tree metrics as shown in Fig. 4.2a. Generally, DSS treatment 
reduced the alpha diversities regardless of the diet, however, the reduction was attenuated with 
BRB diet compared to control diet. Moreover, with control diet, DSS-treated mice were well 
separated from mice without DSS treatment by principal coordinate analysis (PCoA), and the 
separation was much less significant in mice with BRB diet (Fig. 4.2b). Together the diversity 
analysis suggested that, with BRB dietary intervention, reduction in the species richness of the 
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gut microbial communities by DSS was partially restored and the perturbations induced in the 
gut microbial structure were to a relatively small extent. In addition, DSS treatment substantially 
changed the gut microbial composition with a number of significantly-altered gut bacteria. Fig. 
4.2c showed the bacterial genera (B1-B7) that were significantly altered by DSS treatment and 
significantly reversed with BRB dietary intervention. Particularly, increased levels of 
Anaerotruncus (B5) and Trabulsiella (B6) were also found in fecal samples of patients with 
colorectal cancer and Crohn’s disease (Candela et al., 2014; Wright et al., 2017). Taken together, 
the data suggested that DSS-induced perturbations in diversity and composition of the gut 
microbiome were at least in part restored by BRB dietary intervention. 
 
Figure 4.2 DSS-induced perturbations in the gut microbial communities were partly rescued by 
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BRB dietary intervention. a Alpha rarefactions using observed OTUs, chao1 and PD whole tree 
metrics; compared to control subjects, DSS induced significant reduction in alpha diversity, 
which was partly restored by BRB dietary intervention. b The separation assessed by weighted 
UniFrac distance induced by DSS treatment is less significant when mice were fed BRB diet 
(BRB vs BRB+DSS) than control diet (AIN-76A vs AIN-76A+DSS). c The relative abundances 
of gut bacterial genera that were restored with BRB dietary intervention: B1 
(o_Lactobacillales;f_;g_); B2 (f_Lachnospiraceae;g_); B3 (f_Mogibacteriaceae;g_); B4 
(f_Peptostreptococcaceae;g_); B5 (g_Anaerotruncus); B6 (g_Trabulsiella); B7 
(g_Anaeroplasma). (AIN-76A, n=10; AIN-76A+DSS, n=9; BRB+DSS, n=10; *p<0.05) 
4.3.3 Microbiome metabolite profiling and metagenome analysis leads to identification of 
microbiome-derived AHR ligands 
To investigate the mechanism underlying the ameliorating effect of the BRB dietary 
intervention, we examined the AHR activity of cecal contents in mice on different diets. Fig. 
4.3A showed the AHR activation by reporter assay. With control diet, DSS treatment diminished 
the levels of AHR activation. In contrast, with BRB diet, the AHR activity of the cecal contents 
showed no significant difference in mice with or without DSS treatment. Furthermore, mice on 
BRB diet had significantly increased AHR activation compared to mice on control diet 
regardless of DSS treatment, suggesting that BRB diet-modulated gut microbiome had increased 
levels of AHR ligands. To identify specific metabolites that are AHR ligands, we conducted 
untargeted metabolomic profiling using fecal samples of mice fed with control or BRB diet. As 
shown in Fig. 4.3b, the relative abundances of hemin and biliverdin that are previously-reported 
AHR ligands were found to be significantly higher in mice fed with BRB diet compared to mice 
with control diet (Stejskalova et al., 2011). Specifically, hemin was increased by 20-fold and 
biliverdin was increased by 6-fold. Meanwhile, we verified the AHR agonist activities of these 
two metabolites using TCDD as positive control (Fig. 4.3c). To determine whether the gut 
microbiota was a possible source for these metabolites, we conducted functional metagenome 
comparison of the gut microbiome between mice fed with control or BRB diet. We identified 
bacterial pathways and genes that are directly related to heme biosynthesis and transportation, 
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which were significantly more abundant in BRB diet-modulated gut microbiome (Fig. 4.3d&e). 
Taken together, these data indicated that BRB diet-modulated gut microbiome had elevated AHR 
activity, which probably originated from increased bacterial production of AHR ligands 
including hemin and biliverdin. Accumulating evidence suggested the link between AHR 
activation and intestinal inflammation (Goettel et al., 2016; Monteleone, MacDonald, Pallone, & 
Monteleone, 2012; Monteleone et al., 2011). We observed decreased levels of AHR activation in 
mice with elevated intestinal inflammation, confirming the protective role of AHR activation in 
intestinal inflammation. It is previously reported that AHR activation ameliorated DSS-induced 
colitis through prostaglandin E2 (PGE2) production in the colon (Takamura et al., 2010). 
Accordingly, we also observed increased levels of PGE2 in fecal samples of mice with elevated 
levels of AHR activation (Fig. 4.3f), supporting the link of ameliorated intestinal inflammation to 
enhance AHR activation. 
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Figure 4.3 BRB dietary intervention increased the levels of intestinal AHR activation resulting 
from elevated production of microbiome-derived AHR ligands. a DSS-induced intestinal 
inflammation was associated with reduction in AHR activity (AIN-76A vs AIN-76A+DSS); RBB 
consumption significantly increased AHR activity in the microbiome (BRB vs AIN-76A), and 
DSS-induced reduction of AHR activity disappeared if the mice were fed BRB diet (BRB vs 
BRB+DSS). (n=7; two-way ANOVA; ****p<0.0001; *p<0.05; N.S. not significant). b The 
levels of hemin and biliverdin significantly increased in the gut microbiome of mice fed BRB 
diet compared to that fed control diet, which are AHR agonists (c) (n=10; Welch’s two sample t-
test; ***p<0.001). BRB-modulated gut microbiome had enriched bacterial pathways (d) and 
genes (e) involved in the production of heme-related metabolites, which could contribute to the 
increase of hemin and biliverdin (n=6; FDR adjusted p-value; ***p<0.001; *p<0.05). f PGE2, 
the product of AHR-activated anti-inflammatory pathway, significantly increased in mice fed 
BRB diet compared to controls. (n=10; Welch’s two sample t-test; **p<0.01) 
4.3.4 Correlation between gut bacterial species and microbiome-derived AHR ligands 
To further explore the relationship between gut bacteria and AHR ligand production, we 
conducted functional correlation between the gut microbial species and metabolites. Strong 
correlations were identified between the relative abundances of gut bacterial species and the 
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intensities of both hemin and biliverdin (rho>0.8; p<0.001; Fig. 4.4). Specifically, bacterial 
species Methylobacillus flagellates, Teredinibacter turnerae, Cyanothece sp. PCC 7424 and 
Aromatoleum aromaticum are found to be highly correlated with both hemin and biliverdin. In 
addition, Methylobacillus flagellates and Teredinibacter turnerae were reported to possess the 
sets of genes that are involved in heme synthesis and transportation (Chistoserdova et al., 2007; 
Kuehl & Crosa, 2010). These data provided additional evidence that the increased levels of AHR 
ligands in gut could be derived from the gut microbiota. 
 
Figure 4.4 Scatter plots illustrating strong statistical association between the relative abundances 
of specific gut bacterial species and the mass spectrum intensities of microbiome-derived AHR 
ligands hemin and biliverdin, four bacterial species (Methylobacillus flagellates, Teredinibacter 
turnerae, Cyanothece sp. PCC 7424 and Aromatoleum aromaticum) are significantly correlated 
with both hemin and biliverdin. (n=6; rho>0.8; p<0.001) 
4.3.5 Host metabolome analysis 
We examined host plasma metabolome profiles to further investigate host responses to 
the interactions of DSS treatment and BRB dietary intervention using an untargeted 
metabolomics approach. Principal component analysis (PCA) showed that the metabolome 
profile of AIN76-A diet+DSS group was differentiated from AIN76-A diet group. However, 
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both BRB diet and BRB diet+DSS groups totally overlapped within AIN-76A diet group 
indicating more similar metabolic profiles (Fig. 4.5a). As shown in Fig. 4.5b, 788 significantly-
altered features were discovered between AIN-76A diet and AIN-76A diet+DSS groups, and the 
comparison between AIN-76A diet+DSS and BRB+DSS groups revealed 846 significantly-
altered features, which shared 234 features with the former 788 features. Hierarchical clustering 
heat map constructed using the intensities of these 234 shared features showed a clear and 
consistent pattern within individual groups (Fig. 4.5c). Metabolic perturbations induced by DSS 
treatment were largely reversed by BRB dietary intervention, supporting the ameliorating effects 
of BRB on host inflammatory status. Together the data indicated that the host metabolome 
perturbations induced by DSS treatment were partially restored by the BRB dietary intervention, 
confirming the role of the BRB diet in DSS-induced intestinal inflammation. 
We next conducted the identification of those 234 shared features that were restored. A 
number of metabolites (Fig S1) were identified based on the accurate mass, MS/MS spectra and 
database matching. The presence of altered plasma metabolites is associated with host 
inflammatory status and perturbed gut bacterial metabolic activities. Fig.4.5d lists a few 
representative metabolites that were significantly perturbed by DSS, and significantly reversed if 
concurrently with BRB dietary intervention. For instance, bacterial production of uracil favors 
intestinal inflammation (Lee et al., 2013), and indoleacrylic acid produced by the gut bacteria is 
protective against intestinal inflammation(Wlodarska et al., 2017). The involvement of these 
metabolites in inflammatory responses and the gut microbiota suggested the role of gut 
microbiota in the ameliorating effects on intestinal inflammation. 
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Figure 4.5 Metabolic profiling in mouse plasma indicated that DSS treatment significantly 
perturbed the metabolic profiles of mice, which were, at least in part, restored by BRB dietary 
intervention. a The visualization of metabolic profiles in mice from different groups by PCA; 
DSS-induced differences in mouse metabolic profiles disappeared if the mice were concurrently 
fed BRB diet instead of control diet. b Venn diagram of the comparisons of differentiated 
metabolites between groups. c Heat map shows a clear restoration pattern of metabolic features 
by BRB dietary intervention. d Plasma metabolites, including uracil, indoleacrylic acid, S-
Adenosylhomocysteine, 3,4-Dihydroxyphenylglycol and avenanthramide 1f, are significantly 
changed by DSS treatment and significantly reversed by BRB dietary intervention. (n=9; 
Welch’s two sample t-test; *p<0.05) 
4.4 Discussion 
We used a mouse model of experimental colitis and a BRB-rich dietary intervention to 
study the involvement of the gut microbiota in intestinal inflammation. The data clearly show 
that BRB dietary intervention reduced DSS-induced inflammation in mouse colon and increased 
the levels of AHR activation in mouse gut microbiome contents. More importantly, the elevated 
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AHR activation could result from increased production of AHR ligands by gut bacteria. Fig. 4.6 
shows the proposed mechanism regarding the ameliorating effects on intestinal inflammation by 
BRB diet via production of microbiome-derived AHR ligands. Compared to mice on control 
diet, mice on BRB diet suffered less severe intestinal inflammation with DSS treatment. DSS-
induced perturbations in the gut microbiota including their diversity and composition were 
partially restored. Furthermore, increased levels of AHR ligands including hemin and biliverdin 
in the diet-modulated gut microbiome contents lead to enhanced AHR activation, resulting in 
amelioration of inflammation and restoration of metabolic profiles in host via diverse 
mechanisms including production of PGE2. These findings may provide novel insights regarding 
microbiome-derived AHR ligands as a new mechanism of the benefits from dietary supplement, 
such as BRB. More importantly, the production of microbiome-derived AHR ligands offers 
additional evidence on the strong mechanistic link between gut microbiome and host health. 
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Figure 4.6 DSS treatment caused intestinal inflammation and gut microbial disruption, which 
was ameliorated if the mice were concurrently fed BRB diet. BRB dietary intervention increased 
AHR activation in the gut probably resulting from restored gut microbial profiles and enhanced 
production of microbiome-derived AHR ligands, for instance, hemin and biliverdin. Alleviation 
of intestinal inflammatory levels and host metabolic perturbations induced by DSS treatment 
may be attributed to increased intestinal AHR activity via diverse mechanisms including 
production of PGE2. 
Accumulating evidence suggested the association between IBD and gut microbiota even 
though other factors also play important roles such as genetic and environmental elements 
(Bouma & Strober, 2003; Kostic, Xavier, & Gevers, 2014). Maintaining a properly functioning 
gut microbiome is essential to human health. For instance, perturbations such as reduction in 
alpha diversities in the gut microbiota are highly associated with disease risks including IBD (Ott 
et al., 2004). The restoration in gut microbial diversities probably indicated functional 
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restoration. Furthermore, it is well demonstrated that the activation of AHR plays a protective 
role in IBD via modulation of intestinal immune responses and barrier integrity (Goettel et al., 
2016; Metidji et al., 2018). AHR can be activated by a range of ligands that are contributed from 
dietary components or gut microbial activities (Murray & Perdew, 2017). Microbiome-derived 
metabolites are an important source of AHR ligands (Murray & Perdew, 2017). It is suggested 
that, a disrupted gut microbiome that is associated with intestinal inflammation reduces the 
production of microbiome-derived AHR ligands, which leads to decreased AHR ligands 
availability in the intestine, hence decreased intestinal AHR activity. The perturbed AHR activity 
contributes to alterations in gut immune response and barrier functions that further amplify the 
disruption of the gut microbiome in a vicious cycle, favoring chronic intestinal inflammation and 
consequently leading to IBD (Lamas, Natividad, & Sokol, 2018). Thus, restoration of the 
disrupted gut microbiome especially its production of AHR ligands will probably break the 
vicious cycle and ameliorate the intestinal inflammation. We assessed the severity of intestinal 
inflammation and AHR activation in gut contents and found that the inflammation was 
ameliorated in an AHR-dependent manner, confirming the protective role of AHR activation 
against intestinal inflammation. More importantly, increased abundances of bacterial pathways 
and genes related to AHR ligand production as well as strong correlations between bacterial 
species and AHR ligands suggested the involvement of gut microbial activities in the production 
of AHR ligands. The discovery of the association between inflammatory levels and microbiome-
derived AHR ligands in mice elucidated the connection between IBD and gut microbial 
functionality in a significant way. 
The gut microbiota communicates with the host through production of functional 
metabolites (Sharon et al., 2014). Cellular functions and host physiology can be directly altered 
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by bacterial metabolic products. For example, many bacterial metabolites act as signaling 
molecules (Nicholson et al., 2012). Short-chain fatty acids (SCFAs) produced by gut bacteria act 
as signaling molecules through binding to the G-protein-coupled receptors (GPCRs), which 
regulates functions in intestinal immune cells (Rooks & Garrett, 2016). Likewise, tryptophan 
metabolites produced by gut bacteria can bind to AHR affecting gut immune responses (Lamas 
et al., 2016). Previous studies on microbiome-derived AHR ligands mostly focused on 
tryptophan derivatives (Perdew, Murray, & Hubbard, 2015). However, bacteria are known to 
possess the sets of genes and functional pathways in the production of heme-related molecules 
(Anzaldi & Skaar, 2010; Guégan, Camadro, Saint Girons, & Picardeau, 2003; Hopkinson, Roe, 
& Barbeau, 2008; Tong & Guo, 2009), which are also recognized AHR ligands (Nguyen & 
Bradfield, 2007; Stejskalova et al., 2011). The present study found increased levels of hemin and 
biliverdin in gut microbiome contents in concert with elevated genes involved in their 
biosynthesis, providing additional evidence to the reservoir of microbiome-derived AHR ligands. 
These findings also suggest that the search for microbiome-derived AHR ligands is 
underappreciated, more comprehensive screening is warranted. 
Intestinal inflammation is associated with perturbations in host metabolic profiles 
(Schicho et al., 2012), which involves differentiated gut microbial activities (Lu, Knutson, 
Wishnok, Fox, & Tannenbaum, 2012). The integration of a relevant animal model and BRB 
dietary intervention may offer mechanistic insights and explore biomarkers regarding intestinal 
inflammation and gut microbiota. We observed significantly-perturbed metabolite fingerprints in 
plasma of DSS-treatment mice on control diet, however, these perturbations were partially 
restored to normal levels if the mice were concurrently given BRB diet. Specifically, some of the 
restored metabolites are microbiome-derived and inflammation-relevant. For example, the uracil 
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levels in plasma were significantly increased by DSS treatment and back to normal levels with 
the BRB dietary intervention. Uracil may serve as a specific indicator of bacteria-related 
intestinal inflammation because bacterial production of uracil activates the intestinal innate 
immune cells and leads to inflammatory responses (Lee et al., 2013). Likewise, DSS-treated 
mice on control diet had downregulated levels of indoleacrylic acid, which was significantly 
reversed by BRB diet. Indoleacrylic acid can be produced by gut bacteria and is protective 
against intestinal inflammation (Wlodarska et al., 2017). Moreover, we also discovered that S-
Adenosylhomocysteine (SAH) decreased in mice of DSS treatment, which is in accordance with 
the previous report (Lu et al., 2012). Decreased levels of SAH may indicate interrupted 
methylation because SAH is generated when S-Adenosylmethionine (SAM), the methyl donor, 
loses the methyl group. There is growing appreciation of the possible association between 
mucosal DNA methylation and colitis in humans (Kraiczy et al., 2016; Saito et al., 2011). In 
addition, naturally occurring phenolic compounds such as 3,4-dihydroxyphenylglycol and 
avenanthramides with demonstrated anti-inflammatory effects were observed to be upregulated 
in mice on BRB diet, indicating a protective role of BRB possibly resulting from its natural 
components (Aparicio-Soto et al., 2015; Fagerlund, Sunnerheim, & Dimberg, 2009). 
Ligand activation of AHR is an inviting therapeutic approach for intestinal inflammation; 
and dietary modulation of the gut microbiota received increasing attention (Goettel et al., 2016; 
Marchesi et al., 2015). A previously standardized beneficial diet allowed us to study the role of 
microbiome-derived AHR ligands in host physiology. Numbers of recent studies have focused 
on the provision of AHR ligands from dietary components (Hubbard et al., 2017; Metidji et al., 
2018), while our data emphasize the gut microbiota as a major contributor to AHR activation. 
We demonstrated that BRB-modulated gut microbiome contents had elevated AHR activation. It 
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remains to be determined whether components in BRB are direct AHR ligands or precursors. 
Moreover, it is very likely that bacterial metabolites other than hemin and biliverdin are AHR 
ligands. Future studies on the search and identification of microbiome-derived AHR ligands and 
their potential in treating intestinal inflammation are warranted. Although using a food-based 
approach to modulate the gut microbiome has the advantage of low toxicity profiles, the 
limitation of the BRB diet for gut microbiome modulation is the complexity of functional 
components in BRB. Therefore, to modulate the gut microbiome using specific functional 
compound in BRB to reproduce similar effects is warranted in the future to elucidate the role of 
BRB components in altering the functions of the gut microbiome. 
In conclusion, our study provided evidence on the role of microbiome-derived AHR 
ligands in the interactions between diet and intestinal inflammation. Improved host metabolic 
profiles along with restored gut microbial communities indicated the beneficial effects on DSS-
induced colitis by BRB dietary intervention. Importantly, these effects are relevant to 
microbiome-derived AHR ligand production. In addition to providing mechanistic insights into 
the ameliorating effects on intestinal inflammation of BRB, this study offers additional evidence 
on the gut microbiota as a source of AHR ligands, which directly connects the gut microbial 
activities and host health. Our data also offers new thoughts on the treatment of intestinal 
inflammation via dietary modulation of the gut microbial functions. 
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CHAPTER 5 – DIETARY ADMINISTRATION OF BLACK RASPBERRIES 
MODULATES ARSENIC BIOTRANSFORMATION AND REDUCES OXIDATIVE 
STRESS IN MICE 
5.1 Introduction 
Arsenic is naturally present and ubiquitously distributed (Naujokas et al., 2013). Arsenic 
in drinking water mainly from geological sources is a major route of exposure, and over 200 
million people in many countries including Bangladesh, Chile, China, Vietnam, India, and the 
United States face the problem of arsenic-contaminated drinking water (Naujokas et al., 2013). 
Arsenic exposure has been linked to various diseases such as diabetes, cardiovascular disease, 
and bladder, liver, lung, and skin cancers (Hughes, Beck, Chen, Lewis, & Thomas, 2011). It is 
known that arsenic induces oxidative stress leading to deleterious health outcomes, which is one 
of its major pathogenic mechanisms (Jomova et al., 2011). Therefore, monitoring the biomarkers 
of oxidative damage such as 8-oxodG is an effective approach to examine the physiological 
effect of arsenic exposure (Flora, 2011). 
Liver is the major site for arsenic detoxification in mammals, where inorganic arsenic is 
metabolized through a series of methylation and reduction reactions with the involvement of 
relevant enzymes and cofactors (Figure 5.1) (Chi et al., 2018). Generally, inorganic arsenic (V) 
can be converted to inorganic arsenic (III), which is more readily methylated. Then arsenic (III) 
is methylated by methyltransferase with S-adenosylmethionine (SAM) being the major methyl 
donor(Chi et al., 2018). Glutathione S-transferase (GST) is involved converting methylated 
arsenic (V) to methylated arsenic (III) which can be methylated again to form dimethyl arsenic 
metabolites (Chi et al., 2018). The methylated arsenic metabolites, together with some 
113 
unmetabolized inorganic arsenic are readily excreted in urine, which is considered as the 
principal detoxification process of arsenic (Stýblo, Drobná, Jaspers, Lin, & Thomas, 2002). 
Thus, increasing the levels of methylation and urinary excretion can accelerate the process of 
arsenic detoxification. The expression of key enzymes and the abundance of cofactors can 
necessarily affect arsenic biotransformation. In addition, one-carbon metabolism plays a pivotal 
role in arsenic metabolism because one of its important intermediates SAM provides methyl for 
arsenic methylation (Hall & Gamble, 2012). Therefore, nutrients that are involved in one-carbon 
metabolism can also influence the detoxification process of arsenic (Chi et al., 2018). 
 
Figure 5.1 Arsenic biotransformation in mammals. Abbreviations: AS3MT, arsenic (+3) 
methyltransferase; SAM, S-adenosylmethionine, SAH, S-adenosylhomocysteine; GST, 
Glutathione S-transferase; GSH, glutathione; GSSG, glutathione disulfide. 
Berries are well recognized for diverse health effects such as antioxidant, anti-
inflammatory and anticarcinogenic properties (Beattie, Crozier, & Duthie, 2005; Casto et al., 
2002; Knobloch et al., 2016; Oghumu et al., 2017; Seeram, 2008; Stoner, 2009; Tu et al., 2018; 
Warner, Casto, Knobloch, Accurso, & Weghorst, 2014). The rich array of phytochemicals in 
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berry fruit play an important role in these beneficial effects (Howard & Hager, 2007). 
Furthermore, it is reported that consumption of polyphenols, which are abundant in berries, 
affects xenobiotic metabolism via alterations in related enzymes and other factors (Moon, Wang, 
& Morris, 2006; SEERAM & HEBER, 2007). For example, berry phytochemicals confer health 
benefits by regulating enzymes that are important in metabolizing xenobiotics and carcinogens 
(Heber, 2004; Liu, 2003; SEERAM & HEBER, 2007). Likewise, consumption of black tea 
polyphenols impacted multiple enzymes in xenobiotic metabolism in animal models (Murugan, 
Uchida, Hara, & Nagini, 2008; Vidjaya Letchoumy et al., 2008). In particular, curcumin, a 
phenolic compound from turmeric, increased arsenic methylation and urinary excretion and 
reduced oxidative stress in mice (Gao et al., 2013). Modulation of metabolic detoxification 
pathways of environmental toxicants using foods or food-derived components has its advantages 
such as generally low toxicity and high patient compliance. Thus, a better understanding of the 
interactions between foodstuff and arsenic metabolism is necessary for further clinical 
applications (Hodges & Minich, 2015). 
In the present study, we observed a significant reduction of arsenic-induced oxidative 
stress in mice fed a diet rich in BRB. Arsenic biotransformation was greatly changed with 
significantly enhanced methylation and urinary excretion. Key enzymes and cofactors involved 
in arsenic metabolism were altered after BRB consumption, which may account for the changes 
in arsenic biotransformation. This study provides the first evidence that BRB consumption 
impacts arsenic biotransformation and elimination in mice and offers insights regarding the role 
of diet in arsenic metabolism and individual susceptibility. 
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5.2 Materials and methods 
5.2.1 Diet preparation 
BRB diet was prepared essentially as previously described (Oghumu et al., 2017; Tu et 
al., 2018). Briefly, whole ripe BRB (Rubus occidentalis) of the Jewel variety were freeze-dried 
and ground into powder. BRB powder was stored at −20°C until being incorporated into custom 
purified American Institute of Nutrition (AIN)-76A animal diet pellets (Dyets, Inc., Bethlehem, 
PA, USA) by 10% w/w concentration at the expense of cornstarch. The BRB diet used in the 
present study was previously used in a large number of studies for chemopreventive effects 
(Aiyer, Srinivasan, Gupta, & cancer, 2008; Casto et al., 2002; Harris et al., 2001; Kresty et al., 
2001; Stoner et al., 2007). Its preparation was standardized to ensure consistency and 
reproducible results. All berries of a single variety were harvested from a single farm in Southern 
Ohio. Chemical characterization of 26 randomly-selected functional components including 
simple phenols and athocyanins has been conducted for standardization purposes, which together 
with further details regarding the BRB diet was previously discussed and reviewed (Stoner, 
2009). 
5.2.2 Animals and exposure 
Specific-pathogen-free (SPF) C57BL/6 mice (8 weeks of age), purchased from Jackson 
Laboratories (Bar Harbor, ME), were housed in the animal facility of University of Georgia. The 
environmental conditions were maintained as 22°C temperature, 40–70% humidity, and a 12:12 
hour light:dark cycle. Water and standard pelleted rodent diet ad libitum were provided. After 1 
week of acclimation, mice were then randomly assigned into 6 groups (n=10 per group) and 
treated as per the following: 
76: AIN-76A diet and plain water for 6 weeks. 
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BRB: BRB diet and plain water for 6 weeks. 
76+1ppmAs: AIN-76A diet and plain water for 2 weeks, AIN-76A diet with sodium 
arsenite administered in water (1 ppm arsenic) for another 4 weeks. 
BRB+1ppmAs: BRB diet and plain water for 2 weeks, BRB diet with sodium arsenite 
administered in water (1 ppm arsenic) for another 4 weeks. 
76+10ppmAs: AIN-76A diet and plain water for 2 weeks, AIN-76A diet with sodium 
arsenite administered in water (10 ppm arsenic) for another 4 weeks. 
BRB+10ppmAs: BRB diet and plain water for 2 weeks, BRB diet with sodium arsenite 
administered in water (10 ppm arsenic) for another 4 weeks. 
Regular monitoring for health conditions was done twice a week. No significant 
differences were observed regarding water intake and food intake between groups. The mice 
were treated humanely and with regard for alleviation of suffering. Urine samples were collected 
individually at two time points: one day of arsenic exposure and the end of exposure; Tissue 
samples were collected during necropsy and part of liver tissues were treated with RNAlater 
(Thermo Fisher Scientific). All samples were kept at -80°C until further analysis. All 
experiments were approved by the University of Georgia Institutional Animal Care and Use 
Committee. All methods were performed in accordance with the National Institutes of Health 
guide for the care and use of Laboratory animals. 
5.2.3 Urinary 8-oxodG measurement 
Urinary levels of 8-oxodG were measured as previously described with slight 
modification (Zhang et al., 2016). Briefly, 20 μL of urine was mixed with 10 μL of labeled 
internal standard solution (1 μM; 15N5-8-oxodG) before further diluted to 1 mL for instrumental 
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analysis. Identification and quantification were performed with a TSQ Quantis triple quadrupole 
mass spectrometer (Thermo Scientific) operated in positive ion mode with an electrospray 
ionization (ESI) source. The chromatographic separation was carried out using an ACQUITY 
UPLC HSS T3 (2.1 mm × 100 mm, 1.8 µm) column (Waters Inc., Milford, MA, USA). The 
injection volume was 10 µL, and the mobile phase comprised water containing 0.1% formic acid 
(A) and acetonitrile containing 0.1% formic acid (B). The mobile phase gradient was as follows: 
starting at 5% (v/v) B, held for 2 min, increased to 50% B at 5 min, held for 0.5 min, and 
reverted to 5% B within 0.5 min (6th min), and held for 2 min, with a total run time of 8 min. 
Mobile phase was running at a flow rate of 200 μL/min. The source parameters were set as 
follows: spray voltage, 4800 V; sheath gas, 38 arbitrary unit; aux gas, 4 arbitrary unit; sweep gas, 
2 arbitrary unit; ion transfer tube temperature, 300 °C; vaporizer temperature, 300 °C. 
5.2.4 Total arsenic measurement and arsenic speciation 
Arsenic speciation and total arsenic measurement were conducted using an Agilent 
7500cx ICP-MS (Santa Clara, CA) as previously described with minor modification (Lu et al., 
2013). For measurement of total arsenic, 50 mg of tissue samples were incubated with 100 mL of 
high-purity HNO3 for 24 hours and then heated at 85°C for 24 hours. Then, the samples were 
cooled to room temperature, treated with 200 mL of 30% H2O2 and incubated at 85°C for 2 
hours. The cooled samples were injected to an ICP-MS instrument with proper dilution. For 
measurement of urinary arsenic species, the collected urine samples were diluted, and arsenic 
species were separated by a Hamilton PRP-X100 column in an Agilent 1260 HPLC instrument 
with 1 µL of the sample injected into the ICP-MS instrument. The mobile phase A was 10 mM 
ammonium carbonate and 10 mM Tris (pH 8.7), and the mobile phase B was 10 mM ammonium 
carbonate, 10 mM Tris, and 15 mM ammonium sulfate (pH 8.0). The gradient was as follows: 
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(1) 0 to 5 min: 0% B to 100% B; (2) 5 to 11 min: 100% B; (3) 11-17 min: 100% A. 
5.2.5 Quantitative RT-PCR 
Liver RNA was extracted using RNeasy Mini kit (Qiagen) according to manufacturer’s 
instructions. Then RNA was processed with DNA-free™ DNA Removal Kit (Thermo Fisher 
Scientific) to remove DNA contamination according to manufacturer’s instructions. RNA quality 
and concentration were determined using an Agilent TapeStation (Agilent Technologies). 
Reverse transcription was performed with iScript™ Reverse Transcription Supermix (Bio-Rad 
Laboratories, CA) according to manufacturer’s instructions. qPCR was performed with the 
SsoAdvanced™ Universal SYBR® Green Supermix (Bio-Rad) and primers listed in Table S1. 
The reactions were run on a Bio-Rad CFX96 Touch™ Real-Time PCR Detection System using 
the protocol as previously described (Bian et al., 2017). Results were analyzed by the ΔΔCt 
method with CFX manager software (Bio-Rad) using the geometric mean of Gapdh and β-actin 
(Actb) as the internal control. 
5.2.6 Targeted metabolite profiling in liver 
For sample preparation, approximate 20 mg of liver sample was weighed into a 1.5 mL 
Eppendorf tube and extracted with 700 µL of methanol in a TissueLyser (Qiagen) at 50 Hz for 
15 min, followed by centrifugation at 16,000 rpm for 10 min. The supernatant was centrifuged 
again before moving to speed vacuum dry. The analytes were resuspended in 100 µL of 5% 
acetonitrile and passed through a 0.22-µm filter before instrumental injection. A Vanquish 
UHPLC system (Thermo Scientific, Waltham, MA, USA) coupled to a TSQ Quantis triple 
quadrupole mass spectrometer (Thermo Scientific) via an electrospray ionization (ESI) source 
was operated in positive ion mode. The chromatographic separation was carried out using an 
ACQUITY UPLC HSS T3 (2.1 mm × 100 mm, 1.8 µm) column (Waters Inc., Milford, MA, 
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USA). The injection volume was 10 µL, and the mobile phase comprised water containing 0.1% 
formic acid (A) and acetonitrile containing 0.1% formic acid (B). The mobile phase gradient was 
as follows: starting at 5% (v/v) B, held for 0.5 min, increased to 95% B at 5 min, held for 1 min, 
and reverted to 5% B within 0.5 min (6.5th min), and held for 3.5 min, with a total run time of 10 
min. Mobile phase was running at a flow rate of 200 μL/min. Nitrogen and argon was used as 
curtain and collision gas, respectively. The data acquisition was performed at a scan speed of 40 
ms and a resolving power of 0.70 full width at half maximum (FWHM). The source parameters 
were set as follows: spray voltage, 3500 V; sheath gas, 30 arbitrary unit; aux gas, 5 arbitrary unit; 
sweep gas, 6 arbitrary unit; ion transfer tube temperature, 350 °C; vaporizer temperature, 300 °C. 
MRM transitions used for each compound were shown in Table S2. 
5.2.7 Statistical analysis of data 
Unless otherwise indicated, statistical significance was calculated by two-tailed Student’s 
t test (***p<0.001; **p<0.01; *p<0.05; N.S. p>0.05). Results are expressed as mean values with 
standard deviation. 
5.3 Results 
5.3.1 Experimental Workflow 
60 mice were randomly assigned to 6 groups (76, BRB, 76+1ppmAs, BRB+1ppmAs, 
76+10ppmAs, BRB+10ppmAs). Arsenic was administrated in drinking water for 4 weeks with 2 
doses (1ppm & 10 ppm). For examination of oxidative stress, urine at 4 weeks of arsenic 
exposure was collected and 8-oxodG was measured by UPLC-MS. For arsenic speciation and 
total arsenic analysis, urine and tissues were collected and analyzed by HPLC-ICP-MS to reveal 
arsenic biotransformation and deposition. To understand the mechanism underlying the 
interactions between BRB and arsenic metabolism, we extracted RNA from liver to examine the 
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expression of key enzymes in arsenic metabolism. We also extracted liver metabolites to 
investigate the changes of arsenic metabolism-related compounds. 
5.3.2 BRB attenuated arsenic-induced 8-oxodG in urine 
8-oxodG is one of the most commonly-used biomarkers of oxidative DNA damage 
(Valavanidis, Vlachogianni, & Fiotakis, 2009). We measured the urinary levels of 8-oxodG to 
investigate the effects of BRB on mice upon arsenic exposure regarding oxidative stress. As 
shown in Figure 5.2, urinary 8-oxodG was significantly increased by arsenic treatment in both 1 
ppm and 10 ppm concentrations, confirming the role of arsenic to induce oxidative damage. 
More importantly, this effect was markedly reversed by the consumption of BRB. We did not 
observe dose-dependent increases of 8-oxodG in mice with arsenic treatment probably due to 
relatively short time of exposure (4 weeks). Nevertheless, these data suggested that BRB 




Figure 5.2 Urinary levels (nM) of 8-oxodG in control and arsenic-treated mice on 76 or BRB 
diets. Arsenic exposure (1 ppm and 10 ppm) significantly increased the 8-oxodG in mouse urine 
and the effects were significantly reversed if the mice were concurrently fed BRB diet. 
(**p<0.01; *p<0.05) 
5.3.3 BRB changed arsenic biotransformation and increased urinary excretion of arsenic 
To investigate the effects of BRB on arsenic biotransformation, we measured arsenic 
species in urine and discovered significant changes in the spectrum of arsenic metabolites. The 
levels of methylated arsenic metabolites, including MMA and DMA, significantly increased in 
mice fed BRB compared to controls, however, the ratio of MMA to DMA was not significantly 
changed (Figure 5.3). Meanwhile, the levels of inorganic arsenic (iAsIII and iAsV) also 
significantly increased. Furthermore, the total arsenic in urine increased 2-fold in BRB group 
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compared to controls, suggesting increased arsenic excretion with BRB consumption. The data 
here indicated that the arsenic methylation and urinary excretion were significantly elevated by 
BRB consumption, which could be associated with the effects of BRB on reducing arsenic-
induced oxidative stress. 
Elevated excretion of arsenic in mice by BRB was supported by decreased arsenic 
deposition (Figure 5.4). Although other tissues did not show significant differences in total 
arsenic, we observed a significant decrease of total arsenic in lung, suggesting lower arsenic 
deposition in mice with BRB consumption and providing more evidence on elevated arsenic 
excretion. 
 
Figure 5.3 The concentrations (ppb) of urinary arsenic species including monomethylarsonic acid 
(MMA), dimethylarsinic acid (DMA), arsenite (iAsIII) and arsenate (iAsV) as well as 
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MMA/DMA ratio and urinary total arsenic (Total As) in mice of 1 ppm exposure on 76 or BRB 
diets. (**p<0.01; *p<0.05; N.S. p>0.05) 
 
Figure 5.4 The levels (mg/kg) of arsenic in tissues including brain, heart, liver, lung and feces in 
mice of 1 ppm arsenic exposure on 76 or BRB diets. (*p<0.05; N.S. p>0.05) 
5.3.4 BRB induced the expression of genes Gsto1 and Gstt1 encoding enzymes that are 
involved in arsenic metabolism 
As shown in Figure 5.5, the expressions of genes (As3mt, Gsto1 and Gstt1) encoding 
important enzymes in arsenic metabolism were examined by qPCR. Among these, the 
expressions of Gsto1 and Gstt1 showed significant differences with higher expression levels in 
BRB+As than 76+As group. However, BRB alone did not lead to similar effects with no 
significant difference between BRB and 76 diet groups. The expression of As3mt did not shown 
significant difference between different diet groups. However, 76+As group had significantly 
higher expression than 76 group, indicating the induction of As3mt by arsenic exposure. 
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Figure 5.5 Gene expression of enzymes involved in arsenic metabolism in mouse liver of 
different groups. (**p<0.01; *p<0.05) 
5.3.5 BRB changed the levels of important compounds that are involved in arsenic 
metabolism 
One-carbon metabolism is associated with arsenic biotransformation with its intermediate 
SAM as the major methyl donor of arsenic methylation reactions (Hall & Gamble, 2012). Some 
nutrients that are involved in one-carbon metabolism such as folic acid can facilitate the 
methylation and excretion of arsenic (Hall & Gamble, 2012). We next examined the levels of 
important compounds involved in one-carbon metabolism. Figure 5.6 showed the comparisons of 
the levels of SAM, folic acid, GSH and GSSG in mouse liver. The level of SAM significantly 
decreased in BRB+As group compared to 76+As group, consistent with the fact that BRB+As 
group had higher level of arsenic methylation that consumed SAM. In addition, BRB alone 
increased the SAM levels, suggesting direct effect on SAM from BRB thereby affecting arsenic 
biotransformation. Moreover, the level of folic acid is increased in BRB group compared to 76 
group, and the level is decreased in BRB+As group compared to BRB group, suggesting the role 
of folic acid in the effects of BRB on arsenic biotransformation. Arsenic exposure also 
significantly decreased the level of GSSG with lower levels in BRB+As group compared to BRB 
group, however, the levels of GSH did not show significant difference. 
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Figure 5.6 Abundances (nmol/kg) of metabolites related to arsenic metabolism in mouse liver of 
different groups. (***p<0.001; **p<0.01; *p<0.05) 
5.4 Discussion 
Dietary factors are known to play a role in the metabolism of xenobiotics including 
arsenic (Yu, Liu, Li, & Wu, 2016). In this study, we used a mouse model and a BRB-rich diet to 
study the interactions between arsenic biotransformation and consumption of berries. The data 
clearly demonstrated that BRB consumption reduced arsenic-induced oxidative stress and 
enhanced arsenic biotransformation and excretion, which are probably associated with the 
alteration of related enzymes and cofactors. These findings may provide novel insights regarding 
the consumption of foodstuff, especially berry fruit, as a new factor of individual responses upon 
arsenic exposure. 
A BRB-rich diet was used to investigate the impact of berries on arsenic metabolism. The 
selection was grounded in the fact that this specific diet was previously used in a number of 
studies on beneficial effects of BRB (Kresty, Mallery, & Stoner, 2016; Oghumu et al., 2017). 
The diet formula is consistent and standardized (Stoner, 2009). More importantly, BRB contain 
abundant phytochemicals that are potentially active in xenobiotics metabolism (Stevenson & 
Hurst, 2007). Our results are early insights into the relationships between berry fruit 
consumption and arsenic exposure, and the consequent physiological impacts. Arsenic exposure 
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causes oxidative stress through the generation of reactive oxygen species, which is an accepted 
pathogenic mechanism of arsenic toxicity (Kumagai & Sumi, 2007). In the present study, arsenic 
induced an increase of 8-oxodG in mice, which is a critical biomarker for oxidative damage. This 
increase of 8-oxodG was reversed in mice concurrently fed BRB diet, suggesting that the 
negative health effects induced by arsenic exposure were alleviated. Furthermore, urinary 
excretion of arsenic was enhanced 2-fold in concert with lower arsenic deposition in lung of 
mice fed BRB diet compared to control diet. Thus, it appears that BRB consumption increased 
the rate of biotransformation and elimination of arsenic and alleviated the induction of oxidative 
stress. 
To determine whether BRB consumption affects arsenic biotransformation, we measured 
arsenic species in urine and discovered significant changes in the spectrum of arsenic 
metabolites. Among these arsenic metabolites, DMA accounts for more than 90% of the total 
arsenic in urine and the level of DMA in mice on BRB diet was twice as the level in mice on 
control diet. Dimethyl arsenic metabolites are readily excreted in urine (Vahter, 2002). In 
addition, the total arsenic in urine of mice on BRB diet was also twice as mice on control diet. 
The levels of DMA and total arsenic in urine are usually considered as critical indicators of 
arsenic methylation and elimination (Gebel, 2002). Thus, consumption of BRB promoted arsenic 
methylation and accelerated arsenic elimination. A similar study has documented that a phenolic 
compound curcumin also improved the methylation of arsenic and facilitated its excretion in 
urine (Gao et al., 2013). Given the fact that berries contain a variety of phenolic compounds such 
as flavonols and anthocyanins (Määttä-Riihinen, Kamal-Eldin, & Törrönen, 2004; Skrovankova, 
Sumczynski, Mlcek, Jurikova, & Sochor, 2015), it is possible that some specific phenolic 
compounds are involved in arsenic metabolism. 
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Methylation is a major detoxification pathway of arsenic in mammals, with AS3MT as 
the primary methyltransferase and SAM as the main methyl donor (Kumagai & Sumi, 2007). In 
addition to AS3MT, multiple GSTs are also involved in the reduction steps of the methylation 
pathway (Whitbread et al., 2005; Wu et al., 2017). In this study, we found that the expression of 
As3mt in liver was upregulated in mice with arsenic exposure, indicating the induction of 
AS3MT by arsenic. Moreover, with arsenic exposure the expressions of Gsto1and Gstt1 were 
significantly higher in mice on BRB diet compared to mice on control diet, indicating the effects 
of BRB on expressions of GSTs. Because of the differences in the expressions of Gsto1 and 
Gstt1 between different diet groups, the reduction reaction catalyzed by glutathione S-
transferases in methylation process is more likely to be the step that BRB affect. This is 
supported by evidence that phenolic components in berries influence enzymes in xenobiotic 
metabolism including GSTs (SEERAM & HEBER, 2007; Shih, Yeh, & Yen, 2007). Glutathione 
transferase omega 1 (GSTO1-1) catalyzes the rate-limiting step in the biotransformation of 
arsenic in humans (Paiva et al., 2008). The differential expression levels of GSTs may explain 
that, even with similar expression levels of As3mt, mice on BRB diet had accelerated arsenic 
biotransformation compared to mice on control diet. On the other hand, we found that the 
abundances of SAM and folic acid in liver significantly increased with BRB consumption, which 
may be an alternative explanation for the effects of BRB on arsenic biotransformation. The lower 
level of SAM in arsenic-treated mice on BRB diet probably resulted from enhanced arsenic 
methylation, which is supported by increased levels of methylated arsenic metabolites in urine. 
Folic acid is abundantly present in berry fruit and it is previously reported that supplementation 
of folic acid enhanced the methylation to DMA and urinary excretion of arsenic, which is 
consistent with the findings of the present study (Gamble et al., 2006; Gamble et al., 2007; Nile 
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& Park, 2014). 
There is considerable variation regarding individual susceptibility to arsenic toxicity (Chi 
et al., 2018). The underlying mechanisms include genetic variations, dietary factors and 
differences in gut microbiome (Chi et al., 2016; Hernández & Marcos, 2008; Lu et al., 2014; Yu 
et al., 2016). For instance, genetic differences such as genes encoding enzymes that are involved 
in arsenic biotransformation (e.g. AS3MT, GSTs) have been extensively studied (De Chaudhuri 
et al., 2008; Hernández & Marcos, 2008). Moreover, diet and nutritional status also account for 
the individual variation of arsenic metabolism. For example, supplementation of vitamins (e.g. 
folic acid, vitamin C and vitamin E) protects from the adverse effects of arsenic (Chattopadhyay 
et al., 2002; Gamble et al., 2007). The present study provides complementary evidence that 
dietary factors, especially berry fruits, influence arsenic metabolism and biotransformation, 
suggesting a stronger link between specific whole foods and the toxicity of environmental 
chemicals. 
Even though we did observe a significant reduction of 8-oxodG in urine with BRB 
consumption, it is debatable to conclude the health implication of BRB consumption in arsenic 
toxicity given the complex mechanisms underlying the pathogenesis of arsenic-induced diseases. 
Nevertheless, the biotransformation and urinary excretion of arsenic can be significantly 
enhanced in mice by BRB consumption. More comprehensive assessment should be conducted 
to determine the specific role of BRB in arsenic toxicity. In addition, it is of significance to 
pinpoint specific components in BRB that affect arsenic biotransformation for future studies. 
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Figure 5.7 Summary Figure. BRB consumption changed arsenic biotransformation and enhanced 
urinary excretion via alteration of enzyme expression and metabolite abundances in liver leading 
to reduced oxidative stress. 
To conclude, Figure 5.7 shows the mechanism proposed to explain the effects of BRB on 
arsenic metabolism. Key enzymes and cofactors involved in arsenic biotransformation in liver 
are affected leading to increased arsenic methylation and urinary excretion. Elevated levels of 8-
oxodG induced by arsenic treatment were significantly reversed indicating reduced oxidative 
stress after BRB consumption. The findings in this study suggest that BRB consumption exerts 
effects on arsenic biotransformation and provide novel insights regarding the interactions 
between arsenic metabolism and functional foods. 
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CHAPTER 6 – SUMMARY AND FUTURE WORK 
6.1 Summary 
This dissertation focused on characterizing the functional profiles including metabolic 
pathways and metabolites in the gut microbiome upon modulation with dietary administration of 
BRB, as well as the effects of this modulation approach on intestinal inflammation and arsenic 
toxicity. To accomplish the overall goal of this project, my research plan focused on: (1) 
characterizing the taxonomic and functional compositions of the BRB-modulated gut 
microbiome; (2) identifying BRB-driven microbiome-derived metabolites that contribute to 
beneficial health effects; and (3) determining the functional roles of BRB in mediating intestinal 
inflammation and arsenic biotransformation/toxicity through gut microbiome modulation. 
We combined animal models with multi-omic approaches including 16S rRNA 
sequencing, shotgun metagenomic sequencing and mass spectrometry-based metabolomics to 
examine the functional profiles in the gut microbiome upon modulation with dietary 
administration of BRB. Besides the compositional changes including an expected increase of 
beneficial bacterium A. muciniphila, significant alterations in functional pathways and gene 
repertoire were revealed such as vitamin biosynthesis and aromatic amino acid metabolism. 
Moreover, we identified microbial metabolites with increased levels in BRB-modulated gut 
microbiome that probably confer the health benefits of BRB such as tetrahydrobiopterin and 
butyrate. In addition, significantly-increased levels of AHR activation was observed in the gut 
microbiome of mice with BRB consumption. Application of this modulation approach 
ameliorated intestinal inflammation and arsenic toxicity. The potential underlying mechanisms 
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are proposed as below (Figure 6.1). In BRB-modulated gut microbiome, a combination of unique 
precursors in BRB and distinct microbial metabolic activities leads to increased AHR ligands. 
This increased availability of AHR ligands in the intestine leads to increased AHR activity, 
contributing to protective effects on intestinal barrier and immune response, which in turn restore 
the perturbation in the gut microbiota and its functions including production of AHR ligands in a 
virtuous cycle consequently resulting in amelioration of intestinal inflammation and 
improvement of host metabolic profiles. On the other hand, increased AHR activation leads to 
elevated expressions of enzymes involved in arsenic metabolism together with increased levels 
of cofactors from BRB and one-carbon metabolism, contributing to higher-rate arsenic 
metabolism in liver, favoring accelerated arsenic methylation and arsenic excretion and 
consequently reduced oxidative stress. 
 
Figure 6.1 Proposed mechanisms of the effects on intestinal inflammation and arsenic toxicity 
from gut microbiome modulation by BRB 
6.2 Future work 
We demonstrated that BRB-modulated gut microbiome contents had elevated AHR 
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activation. It remains to be determined whether components in BRB are direct AHR ligands or 
precursors, or the combination. Moreover, it is very likely that bacterial metabolites besides 
hemin and biliverdin are AHR ligands. Future studies on the search and identification of 
microbiome-derived AHR ligands and their potential in treating intestinal inflammation are 
warranted.  
Although using a food-based approach to modulate the gut microbiome has the advantage 
of low toxicity profiles, the limitation of the BRB diet for gut microbiome modulation is the 
complexity of functional components in BRB. Therefore, to modulate the gut microbiome using 
specific functional compound in BRB to reproduce similar effects is warranted in the future to 
elucidate the role of BRB components in altering the functions of the gut microbiome. 
Additionally, we demonstrated that BRB consumption modulated the gut microbiome and 
associated functions. However, future studies are warranted to delineate the mechanistic basis of 
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Supplementary Figures 
Figure S1. Gut microbial comparisons at phylum level in the BRB diet and control groups. 
 
Figure S2. The fold changes of significantly altered gut bacterial genera in the BRB diet group 
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Supplementary Tables 
Table S1. List of identified fecal metabolites that are significantly elevated in mice of BRB diet 






Diaminopimelic acid 2.8 2.00E-04 1.1 191.101 Alpha amino acids 
N5-(4-
Methoxybenzyl)glutamine 
2.4 3.50E-05 4.3 267.135 Alpha amino acids 
2-Aminobenzoic acid 42.7 6.30E-07 6.6 138.056 Aminobenzoic acids 
[2-(Dimethoxymethyl)-1-
heptenyl]benzene 
8.9 7.10E-06 8.8 249.184 Benzene and substituted derivatives 
4-Methyl-1-phenyl-2-
pentanol 
4.3 1.70E-05 12.3 179.141 Benzene and substituted derivatives 
Biliverdin 5.6 7.80E-05 9.7 583.257 Bilirubins 
Tetrahydrobiopterin 995.7 4.00E-04 8.8 242.127 Biopterins and derivatives 




15.2 6.00E-06 12 429.371 Cholesterols and derivatives 
N6-Acetyl-L-lysine 6.6 2.20E-05 2.1 189.123 D-alpha-amino acids 
Alanyl-Isoleucine 6.1 6.60E-04 3.8 203.137 Dipeptides 
Alanyl-Phenylalanine 4.6 7.20E-06 5.1 237.123 Dipeptides 
Asparaginyl-Leucine 2.7 3.30E-04 1.7 246.145 Dipeptides 
Glycyl-Methionine 5 7.10E-05 2.4 207.082 Dipeptides 
Glycyl-Phenylalanine 2.8 1.40E-03 5.1 223.108 Dipeptides 
Isoleucyl-Isoleucine 4.5 4.20E-03 6.6 245.184 Dipeptides 
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Leucyl-Isoleucine 3.1 5.00E-06 5.7 245.184 Dipeptides 
Leucyl-phenylalanine 3.8 5.40E-04 5.9 279.171 Dipeptides 
Leucyl-Serine 2.1 4.30E-03 1.8 219.133 Dipeptides 
Leucyl-Threonine 4 8.90E-04 2.6 233.149 Dipeptides 
Methionyl-Threonine 4.7 5.30E-04 2.9 251.106 Dipeptides 
Phenylalanyl-Valine 5.1 1.80E-03 5.4 265.155 Dipeptides 
Serylisoleucine 4.6 4.80E-04 4.3 219.135 Dipeptides 
Serylvaline 7.1 3.90E-03 1.9 205.117 Dipeptides 
Valyl-Serine 2.4 1.00E-03 1.2 205.117 Dipeptides 
Valyl-Valine 3.1 1.90E-04 4.2 217.152 Dipeptides 
Cinncassiol D4 2-
glucoside 
10.8 5.70E-07 8 515.285 Diterpene glycosides 
Ergosterol 9.5 2.20E-04 11.7 397.344 Ergosterols and derivatives 




46.5 3.60E-05 3.7 773.214 Flavonoid-3-O-glycosides 
4-Guanidinobutanoic acid 5 9.50E-04 1.5 146.093 Gamma amino acids and derivatives 
Galactosylhydroxylysine 3.4 5.90E-05 1.7 325.162 Glycosyl-amino acids 
Protocatechuic acid 889.5 1.30E-06 4.9 155.034 Hydroxybenzoic acid derivatives 
Dehydrozingerone 35.9 3.60E-03 6.1 193.087 Hydroxycinnamic acids and derivatives 
5,6-Dihydro-11-
methoxyyangonin 
5.1 2.50E-05 1.1 291.123 Kavalactones 
Pyrraline 3.1 1.00E-03 2.5 255.132 L-alpha-amino acids 
Kinocoumarin 44.7 7.50E-04 10 381.208 Linear pyranocoumarins 
15,16-DiHODE 1.9 2.10E-03 9.5 313.235 Lineolic acids and derivatives 
Alpha-Linolenic acid 3 1.60E-05 12 279.231 Lineolic acids and derivatives 
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Corchorifatty acid A 8.6 1.90E-04 9.3 309.203 Lineolic acids and derivatives 
Stearidonic acid 10.9 8.70E-06 12.3 277.215 Lineolic acids and derivatives 
12,13-DHOME 2 9.50E-03 10.4 315.251 Long-chain fatty acids 
15(16)-EpODE 2.9 1.50E-04 8.5 295.225 Long-chain fatty acids 
N-Oleoylethanolamine 3.5 5.80E-03 13.5 326.305 N-acylethanolamines 
menaquinone-1 3.6 3.00E-03 4.7 243.135 Naphthalenes 
Alanyl-Leucine 3.2 4.70E-05 4.7 203.14 Peptides 
Protoporphyrin IX 18 3.20E-05 13.7 563.266 Porphyrins 
15-Deoxy-d-12,14-PGJ2 9.1 4.60E-06 12.3 317.208 Prostaglandins and related compounds 
Prostaglandin E2 2.6 1.50E-03 8.8 353.235 Prostaglandins and related compounds 
1-Pyrroline 3937.9 9.50E-06 2.5 70.0665 Pyrrolines 
Bisacurone epoxide 13 9.90E-07 5.9 269.175 Sesquiterpenoids 
13'-Hydroxy-alpha-
tocopherol 
4869.8 1.10E-06 11.9 447.379 Tocopherols 
13'-Carboxy-alpha-
tocotrienol 
2.9 4.40E-08 8.9 455.319 Tocotrienols 
Alpha-Tocotrienol 4.9 1.10E-06 11.2 425.339 Tocotrienols 
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Table S1. List of serum metabolites that are significantly perturbed by DSS treatment and 
significantly restored by BRB (p<0.05). 










127.0363 2.3 [M+Na]+ 1.6 0.6 
2-Aminoheptanoate 146.1173 4.8 [M+H]+ 18.1 0.2 
2-Oxoarginine 174.0878 1.4 [M+H]+ 0.6 2.1 
3,4-
Dihydroxyphenylglycol 
171.0621 2.9 [M+H]+ 0.2 3.3 
3-Hydroxyanthranilic 
acid 
154.0473 3.0 [M+H]+ 2.7 0.3 
9-Decenoylcarnitine 314.2323 8.4 [M+H]+ 1.2 0.6 
Avenanthramide 1f 314.1091 1.6 [M+H]+ 0.4 6.0 
Casuarine 6-alpha-D-
glucoside 
368.1530 5.0 [M+H]+ 0.5 1.8 
Cyclohexylamine 100.1113 4.0 [M+H]+ 5.9 0.2 
Furanone A 85.0289 1.5 [M+H]+ 1.6 0.6 
Indoleacrylic acid 188.0741 5.0 [M+H]+ 0.4 1.6 
N-(1-Deoxy-1-
fructosyl)leucine 
294.1537 3.9 [M+H]+ 0.6 2.8 
N-(1-Deoxy-1-
fructosyl)methionine 
312.1104 1.7 [M+H]+ 0.4 5.3 
N-(1-Deoxy-1-
fructosyl)phenylalanine 
328.1383 4.5 [M+H]+ 0.7 2.7 
N-(1-Deoxy-1-
fructosyl)tyrosine 
344.1333 2.2 [M+H]+ 0.7 2.7 
N-(1-Deoxy-1-
fructosyl)valine 
280.1369 1.6 [M+H]+ 0.6 2.9 
Nigellic acid 281.1396 1.6 [M+H]+ 0.5 2.8 
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Proline betaine 144.1020 1.2 [M+H]+ 0.5 1.9 
S-
Adenosylhomocysteine 
385.1360 1.7 [M+H]+ 0.6 2.8 
Serotinose 313.1136 1.6 [M+H]+ 0.4 5.6 
Succinyladenosine 384.1147 4.7 [M+H]+ 0.6 1.9 
Tocopheronic acid 295.1565 3.1 [M+H]+ 0.6 2.6 
Uracil 113.0310 2.0 [M+H]+ 1.6 0.6 
z-Clausenamide 302.1183 1.5 [M+Na]+ 0.5 3.2 
*Fold change: Fold change is calculated as the ratio of AIN-76A+DSS versus AIN-76A and BRB+DSS 
versus AIN-76A+DSS 
Table S2. Primers for quantatative RT-PCR. 
Gene Forward primer Reverse primer Reference 
TNF-α CCCTCACACTCAGATCATCTTCT GCTACGACGTGGGCTACAG Alkhouri et al., 2010 
IL-6 TAGTCCTTCCTACCCCAATTTCC TTGGTCCTTAGCCACTCCTTC Alkhouri et al., 2010 
IL-1β GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT Alkhouri et al., 2010 
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APPENDIX D: SUPPORTING INFORMATION FOR CHAPTER 5 
Supplementary Tables 
Table S1. Primers for quantitative RT-PCR. 
Gene Forward primer Reverse primer Reference 
As3mt CCAGGGCCGTTCTGAGTT TGTCCTTTAGCCACCCTCTTG Perry et al., 2012 
Gsto1 GGATGAGGCCTACCCAGAGA CAAAGGCGGCACCTTAGAGA Wu et al., 2017 
Gstt1 CTGTACCTGGATCTGCTGTCG TAGCCACACTCTCACACAGGG Wu et al., 2017 
Gapdh ACCACAGTCCATGCCATCAC CACCACCCTGTTGCTGTAGCC Park et al., 2010 
β-actin  CGTGCGTGACATCAAAGAGAA  TGGATGCCACAGGATTCCAT Song et al., 2015 
 
Table S2. MRM transitions and instrumental parameters for targeted metabolite profiling in liver 












Betaine 118 58 27 103 
Choline 104 60.071 18 95 
Cysteine 122.1 58.988 21 62 
Folic acid 442.15 295.125 15 134 
GSH 308 179.071 13 121 
GSSG 613.2 355.054 22 232 
Methionine 149.95 132.97 11 74 
SAM 399.1 250.083 16 143 
Supplementary Figures 
Figure S1. Abundances (nmol/kg) of other metabolites in one-carbon metabolism that did not 
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